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CHAPTER I 
 
INTRODUCTION 
 
The mammalian pancreas arises from separate ventral and dorsal evaginations of 
foregut endoderm that develop posterior to the stomach anlage and subsequently fuse to form 
the mature pancreatic organ (Fig. 1.1; reviewed by Slack, 1995).  Endoderm-derived 
precursors in the early pancreatic epithelium differentiate to give rise to acinar cell clusters, 
which produce digestive enzymes, a ductal network that transports the enzymes to the 
duodenum, and the endocrine islets of Langerhans, spherical clusters of hormone-producing 
cells interspersed amongst the exocrine pancreatic tissue (i.e., the acinar cells and ducts).   
The pancreatic islets are derived from common endocrine progenitor cells (Gu et al., 
2002) that differentiate to produce the four major pancreatic endocrine cell lineages -- the 
insulin-producing β cells, glucagon-producing α cells, somatostatin-producing δ cells, and 
pancreatic-polypeptide-producing PP cells -- in a ratio of approximately 75:15:6:4 (Cabrera 
et al., 2006; Brissova et al., 2005).  In mice, the pancreatic islets are stereotypically organized 
with the β cells in the core of the sphere and the other three cell types around the periphery 
(Fig. 1.1E).  Because the islets are a mammal’s major source of insulin and glucagon 
production, they are essential for maintenance of glucose homeostasis.  The pathways that 
regulate pancreas development have attracted clinical interest because mutations in 
components of these pathways have been linked to congenital disorders resulting in heritable 
forms of diabetes mellitus (reviewed by Bell and Polonsky, 2001).  More recently, 
understanding the embryonic regulation of pancreas development has come to be viewed as  
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essential for developing techniques to generate functional, transplantable β cell replacements 
from cultured progenitor cells (reviewed by Keller, 2005). 
 The homeodomain transcription factor Pancreatic and Duodenal Homeobox 1 (Pdx1), 
a member of the Parahox family of Hox-like transcription factors (Brooke et al., 1998), has 
emerged as a central node in the genetic network governing ontogenesis of the pancreas and 
neighboring tissues of the posterior foregut (e.g., Fig. 1.2; reviewed by McKinnon and 
Docherty, 2001; Shih and Stoffel, 2001; Servitja and Ferrer, 2004).  The diversity of inputs 
regulating Pdx1 expression and the pleitropic roles of Pdx1 during foregut development 
make it an attractive model for elucidating the principles governing tissue-specific gene 
expression and cell fate differentiation.   
Recent large-scale efforts to characterize the cis-regulatory motifs that regulate tissue-
specific gene expression have revealed a general trend that cis-elements governing 
expression in mature tissues are often much shorter and less complex than the sequences that 
regulate expression during embryogenesis (reviewed by Ochoa-Espinoza and Small, 2006).  
The main reason for this disparity is probably that mature tissues typically express a core set 
of transcription factors that activate many of the genes involved in the adult function of that 
tissue, whereas embryological transcriptional regulation requires interpretation of morphogen 
gradients and fluctuating levels of broadly expressed and overlapping transcription factors to 
specify distinct cell and tissue fates.  This model of cis-regulatory complexity aptly describes 
the regulation of Pdx1.  Sequences of as little as 200 bp from the 5’ non-coding region of 
Pdx1 have been shown to be sufficient to promote reporter gene expression specifically in β 
cells of adult mice (Samaras et al., 2002).  By contrast, there are more than 2 kb of non-
coding sequence in the Pdx1 locus showing greater than 70% identity between mouse and  
 4 
 5 
human sequences (see Fig. 1.6), a level of conservation suggesting potential regulatory 
function (e.g., Gerrish et al., 2000).  Diverse subsets of these conserved sequences have been 
shown to recapitulate aspects of the expression pattern of Pdx1 in developing endoderm, 
suggesting that the developmental expression of Pdx1 is regulated cooperatively by multiple 
spatially segregated elements rather than through a single core enhancer element.   
The main focus of my thesis research was to characterize further the cis-regulatory 
regions required for tissue-specific expression of Pdx1 and to identify additional roles of 
Pdx1 in the diverse developing and mature tissues where it is expressed.  Subsequent sections 
of this introduction review (1) the early patterning events that regulate expression of Pdx1 in 
the posterior foregut and pancreatic buds, (2) the cis-elements of Pdx1 that regulate its 
transactivation, (3) the developmental and physiological functions of Pdx1, and (4) the 
specific aims of my thesis research. 
 
Part I -- Early patterning of the endoderm and induction of Pdx1 expression 
 
Initiation of Pdx1 expression 
Pdx1 is the earliest factor known to be expressed specifically in the nascent 
pancreatic buds, although its domain of expression soon expands to include the endodermal 
progenitors of the caudal stomach, rostral duodenum and common bile duct (reviewed by 
Gannon and Wright, 1999).  The mechanism by which Pdx1 expression is initiated and 
restricted to foregut endoderm remains largely unknown.  The first endodermal precursors to 
migrate through the primitive streak give rise to anterior endoderm and later migrating 
precursors give rise to posterior endoderm (reviewed by Wells and Melton, 1999).  By the 
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end of gastrulation, intrinsic anterior-posterior (AP) polarity of the definitive endoderm is 
already apparent, based on the regionalized expression of Cerl (Bouwmeester et al., 1996), 
Otx1 (Rhinn et al., 1998), Hex (Thomas and Beddington, 1996), IFABP (Green et al., 1992) 
and Cdx2 (Beck et al., 1995) in E7.5 mouse embryos.  Pdx1 is first detected in ventral 
endoderm at the lip of the anterior intestinal portal at the 7 somite stage (~E8.0) (Fig. 1.3; 
Gannon and Wright, 1999).  Deutsch et al. (2001) isolated this region of endoderm at the 2 – 
6 somite stage and demonstrated that it autonomously activated Pdx1 after 2 days in culture.  
A similar result was obtained from cultures of chick ventral endoderm, and it was shown that 
only endoderm from the appropriate AP level would activate Pdx1 expression in culture, 
indicating that regional patterning of ventral pancreatic fate occurs prior to the onset of Pdx1 
expression (Kumar et al., 2003).  Deutsch et al. also showed that the expression of Pdx1 
could be abrogated in favor of liver gene activation by co-culture with cardiogenic 
mesoderm, which suggested that the anterior extent of the ventral Pdx1 expression domain 
may be limited by the heart-forming region.  The effect of cardiogenic mesoderm on ventral 
endoderm culture could be mimicked by FGF2, which had been previously shown to inhibit 
Pdx1 expression in frog embryos (Gamer and Wright, 1995). 
 Unlike the ventral pre-pancreatic endoderm, the dorsal pre-pancreatic endoderm did 
not activate Pdx1 expression in culture (Deutsch et al., 2001).  This difference appeared to 
correlate with the induction of Shh expression in cultured dorsal endoderm but not in ventral 
pre-pancreatic endoderm.  It had previously been shown that inhibition of expression of Shh 
in dorsal endoderm is required for induction of dorsal Pdx1 expression in chick (Hebrok et 
al., 1998).  Repression of Shh is normally provided by signals from the notochord (Hebrok et  
 7 
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al., 1998, Kim et al., 1997), which could be mimicked by activin or low levels of FGF2.  
High levels of FGF2 inhibited Pdx1 expression and enhanced Shh expression (Hebrok et al., 
1998).  Ptc-/- mice do not activate Pdx1 expression, which implies that overactive Hedgehog 
signaling inhibits initiation of Pdx1 expression in mice as in chickens (Hebrok et al., 2000).  
Although the Hedgehog inhibitor cyclopamine induced formation of ectopic pancreatic tissue 
in the chick stomach and duodenum, the Pdx1 expression domain was not notably expanded 
after cyclopamine treatment (Kim and Melton, 1998) nor in Shh-/- mice (Hebrok et al., 2000).  
Along with the finding that notochord could not induce Pdx1 expression in non-pancreatic 
endoderm (Kim et al., 1997), these results indicate that repression of Shh is permissive but 
not instructive for Pdx1 expression (Fig. 1.4).   
 
Inductive signals from mesoderm 
 Studies in frog (Horb and Slack, 2001) and chick (Kumar et al., 2003) have shown 
that lateral plate mesoderm (LPM) from the AP level of the pancreatic buds can induce Pdx1 
expression in anterior regions, but not posterior regions, of early endoderm.  Futhermore, 
hindgut LPM was shown to inhibit pancreas differentiation and induce expression of the 
intestinal transcription factor Cdx in the pancreatic endoderm (Kumar et al., 2003).  These 
studies suggest that regional patterning of the mesoderm instructs the fate of underlying 
endoderm, a model that is reminiscent of previous reports of the nested pattern of Hox gene 
expression in the hindgut mesoderm imparting regional patterning on the endoderm (Fig. 1.4; 
reviewed in Roberts, 2000).  More recently, mesodermal expression of Sox9 and Nkx2.5 has 
been shown to be instructive for differentiation of pyloric sphincter endoderm (Theodosiou 
and Tabin, 2005), and expression of Barx1 in mesoderm of the developing stomach is  
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required for differentiation of stomach endoderm (Kim et al., 2005).  Thus, crosstalk between 
mesoderm and endoderm seems to be a general mechanism for patterning of the gut and is 
probably instructive for positioning the pancreatic buds and inducing expression of Pdx1. 
 One candidate proposed to be a critical mesodermal signal promoting Pdx1 
expression is retinoic acid (RA).  RA signaling from mesoderm to endoderm has been shown 
to be necessary and sufficient for formation of insulin-producing cells in zebrafish (Stafford 
et al., 2006).  Ectopic RA can induce Pdx1 expression in anterior endoderm in zebrafish 
(Stafford and Prince, 2002) and chick (Kumar et al., 2003), although it requires the presence 
of additional permissive mesodermal factors.  Raldh2-/- mice are deficient in production of 
RA and fail to initiate dorsal Pdx1 expression, although expression in the ventral pancreatic 
bud appears to be unimpaired (Martin et al., 2005; Molotkov et al., 2005).  These results 
indicate that RA signaling is an important component for establishment of the Pdx1 
expression domain, but given the broad expression of RA in posterior tissues of the embryo, 
it is unlikely that RA alone can account for the precise positioning of the pancreatic buds. 
 After initiation of Pdx1 expression, signals from neighboring mesodermal structures 
continue to be important for maintenance of Pdx1 expression and pancreatic outgrowth.  The 
LIM homeodomain transcription factor Isl1 begins to be expressed in the dorsal pancreatic 
bud and dorsal pancreatic mesenchyme shortly after onset of Pdx1 expression.  In Isl1-/- 
mice, the dorsal pancreatic mesenchyme is absent, resulting in loss of Pdx1 expression and 
aborted outgrowth of the dorsal bud (Ahlgren et al., 1997).  The supportive role of the dorsal 
mesenchyme appears to be mediated at least in part by FGF10 (Bhushan et al., 2001).  
Signals from the endothelial cells of the dorsal aorta are also required for maintenance of 
Pdx1 expression and dorsal bud outgrowth (Yoshitomi et al., 2004; Lammert et al., 2001), 
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although endothelial cells do not appear to be required for early stages of ventral bud 
development (Yoshitomi et al., 2004). 
 
Maturation of the Pdx1 expression domain 
Pdx1 is expressed in all epithelial cells of the pancreatic bud except for the early 
differentiating glucagon and insulin cells (Ahlgren et al., 1996).  The early hormone-positive 
cells do not appear to be the progenitors of the mature islets, as genetic lineage tracing 
experiments indicate that Pdx1 is expressed by progenitors of all of the endoderm-derived 
components of the mature pancreas (Gu et al., 2002).  Between E9.5 and E12, expression of 
Pdx1 spreads to include the epithelial progenitor cells of the antropyloric stomach, the rostral 
duodenum and the common bile duct (Fig. 1.5; Offield et al., 1996).  As embryogenesis 
progresses, Pdx1 is upregulated in differentiating β cells and downregulated to lower levels 
of expression in the exocrine pancreas and gut epithelia (Fig. 1.5; Guz et al., 1995; Offield et 
al., 1996).  In adult mice, Pdx1 is highly expressed in all pancreatic β cells and some δ 
(somatostatin-producing) cells.  It is expressed at a low level in pancreatic acinar cells, some 
pancreatic duct cells, the antropyloric mucosa of the stomach, rostral duodenal epithelium, 
duodenal Brunner’s glands and the epithelial lining of the common bile duct. 
 
 
 12 
 13 
Part II -- Regulation of Pdx1 transcription 
 
 The literature reviewed above provides compelling evidence that intercellular 
signaling pathways are critical for the establishment and maintenance of Pdx1 expression.  
Surprisingly little is known about regulation of the Pdx1 promoter by the intracellular 
effectors of these signaling pathways.  Instead, the bulk of known regulatory interactions on 
Pdx1 are mediated by transactivators expressed intrinsically in the endoderm.  Whether the 
activity of these transactivators on the Pdx1 locus is modulated by intercellular signaling 
pathways remains to be demonstrated. 
 
Early studies of the Pdx1 promoter 
 Initial characterization of transactivation of Pdx1 was accomplished by in vitro 
promoter deletion and DNase footprinting analysis of the rat Pdx1 (STF1) 5’ region (Sharma 
et al., 1996, 1997).  These studies revealed that a proximal E box consensus sequence located 
-104 bp from the transcription start site is important for transcription of Pdx1 and is bound by 
the ubiquitous basic helix-loop-helix (bHLH) factor USF in β cell lines and in HeLa cells, 
suggesting that it is essential for basal transcription of Pdx1 but not for specific activity in β 
cells (Sharma et al., 1996).  A more distal region of the rat Pdx1 promoter (-6200 to -5670 
bp) was found to confer β-cell-specific activity.  Examination of the sequence of this distal 
region revealed the presence of FoxA and E box consensus sequences (Sharma et al., 1997).  
DNase I protection and gel shift assays confirmed that the FoxA element was bound by FoxA 
factors and that the E box was bound by a heterodimer of NeuroD/Beta2 and E47.  
Furthermore, the ability of FoxA2 to activate this region could be inhibited by treatment with 
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the glucocorticoid dexamethasone.  A more recent study compared the -6200 to -5670 bp 
region of rat Pdx1 to the human, mouse and chicken Pdx1 sequences and revealed that this 
region, referred to as Area IV, is evolutionarily conserved, and that the mouse and human 
sequences have β-cell-specific enhancer activity (Gerrish et al., 2004).  Gel shift and 
chromatin immunoprecipitation (ChIP) assays confirmed conservation of the FoxA2 binding 
site originally identified in rat Area IV and also demonstrated binding of Nkx2.2 and Pdx1 
itself to Area IV.  The terminal G of the E box consensus (CANNTG) is changed to an A in 
the mouse Area IV sequence, suggesting that NeuroD/Beta2 may not be able to bind to 
mouse Area IV. 
 Independent efforts identified a more proximal region of the Pdx1 promoter that also 
promotes β-cell-specific transcriptional activation.  In the first study to characterize this 
region, three DNase hypersensitive sites were identified in Pdx1 genomic DNA isolated from 
β cell lines but not NIH3T3 cells, suggesting that nucleosomes are displaced from these 
regions by transcription factor binding in β cells (Wu et al., 1997).  One of these 
hypersensitive sites (-2560 to -1880 bp) promoted reporter gene activity specifically in β 
cells.  Furthermore, a 1 kb restriction fragment overlapping this region (PstI-BstEII, aka PB; 
-2917 to -1918 bp) promoted lacZ reporter activity in the pancreatic islets of transgenic mice.  
A FoxA2 binding element was identified in this region and mutation of the FoxA2 element 
reduced transcriptional activity of the PB region.   
 
Identification of evolutionarily conserved sequences 
Two groups aligned mouse and human Pdx1 sequences including approximately 4.6 
kb 5’ of the Pdx1 coding region (Fig. 1.6; Gerrish et al., 2000; Marshak et al., 2000).  Both  
Exon 1 Exon 2
IIIIII
IVa b
-4.5 kb
Fig. 1.6  Vista alignment of mouse and human Pdx1 genomic sequences.  Non-
coding regions containing at least 100 bp of >70% identity are shaded pink, exons are
shaded purple, and untranslated regions are shaded light blue.  Previously
characterized conserved regions are labeled with roman numerals.  Two
uncharacterized distal conserved regions are labeled “a” and “b”.  Black arrow
indicates approximate position of the XbaI site at -4.5 kb that has often been used as
the 5’ end of Pdx1-promoter-driven transgenes.  Alignment was generated using the
Lawrence Berkeley Laboratories’ online Vista browser (http://pipeline.lbl.gov).
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Fig. 1.7  Summary of transactivator binding to Pdx1 promoter.  Top, previously
reported sites of protein-DNA interactions in relation to phylogenetically conserved
cis-elements.  HSS1 indicates approximate span of DNase hypersensitive site 1 (Wu et
al., 1997).  The PB region is delimited by the indicated PstI and BstEII restriction
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groups identified four regions of greater than 75% identity, which included the sequence 
around the transcription start site and three areas clustered in a 1.2 kb region overlapping the 
DNase hypersensitive site characterized by Wu et al.  These three areas, in order from 5’ to 
3’, are typically referred to as Areas I, II, and III in mice and PH1, 2 and 3 in humans.  Areas 
I and II are contained in the PB fragment (Fig. 1.7) and each has β-cell-specific activity in 
isolation (Gerrish et al., 2000; Marshak et al., 2000) and synergistic activity in combination 
(Van Velkinburgh et al., 2005).  FoxA2 was found to bind and activate Areas I and II 
(Gerrish et al., 2000; Marshak et al., 2000).  Also, Pdx1 itself was shown to bind and activate 
Area I cooperatively with FoxA2, which was the first demonstration of Pdx1 autoregulation 
(Marshak et al., 2000).   
Subsequent block mutational analysis of subregions of Areas I and II revealed 
additional sites for binding and activation of Area I by Hnf1α (Gerrish et al., 2001) and 
Nkx2.2 (Van Velkinburgh et al., 2005), and of Area II by Pax6 (Samaras et al., 2002) and 
MafA (Samaras et al., 2003).  Binding of Hnf6 has been demonstrated by gel shift analysis of 
sites in Areas I and III and also to a site midway between Areas I and IV (Jacquemin et al., 
2003).  This intermediate region of the human Pdx1 (IPF1) promoter was shown to bind the 
transcription factors Sp1, Sp3, FoxA2 and Hnf1α, although these sites do not appear to be 
conserved in the mouse sequence (Ben-Shushan et al., 2001).  Interestingly, all of the binding 
activities characterized on the Pdx1 promoter are positive regulatory interactions.  Promoter 
deletion and mutation experiments have provided evidence of repressor elements (Sharma et 
al., 1997; Samaras et al., 2002), but protein binding to these elements has not been 
characterized. 
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Analysis of lacZ reporter transgenes 
Activities of some of the cis-regulatory elements described above have been 
characterized in transgenic and gene-targeted mice.  The shortest sequence shown to promote 
transgenic reporter activity selectively in β cells is the ~200 bp comprising evolutionarily 
conserved Area II, although reporter activity was detected in less than 50% of β cells 
(Samaras et al., 2002).  Combination of Area II with Area I sequences either by direct 
juxtaposition of these elements (Van Velkinburgh et al., 2005) or in the context of the PB 
region (Wu et al., 1997) promoted reporter expression in nearly all β cells.  Of the factors 
shown to bind to Area II, FoxA2 and Pax6 are expressed in endocrine progenitors and mature 
β cells, whereas MafA (Nishimura et al., 2006; Matsuoka et al., 2003, 2004) is restricted to 
the mature β cells that begin to appear during the so-called “secondary transition” period of 
pancreas development between E13.5 and E15.5 in mouse.  Onset of expression of an 
AreaI+II-lacZ transgene was observed at E14.5 in insulin-positive cells, consistent with the 
timing and location of MafA expression (Van Velkinburgh et al., 2005).  Also, Van 
Velkinburgh et al. proposed that binding of Nkx2.2 to Area I may be important to boost the 
β-cell-specific activity of Area II to a sufficient level for reporter expression to be detectable 
in most β cells. 
While the highly conserved elements of Areas I and II promote transcription 
primarily in differentiating and mature β cells, broader activity within the Pdx1 expression 
domain has been demonstrated for longer regions of the 5’ Pdx1 promoter.  Stoffers et al. 
(1999) analyzed the developmental expression of a lacZ reporter transgene driven by the 
proximal 4.6 kb of Pdx1 promoter sequence (from the Xba I site at -4.5 kb to the start codon 
at +92 bp), demonstrating that it recapitulated the endogenous ontogenesis of Pdx1 
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expression.  Gannon et al. (2001) extended this analysis by examining transgenic lacZ 
expression using several fragments from the 4.6 kb promoter.  The general trend to emerge 
was that shorter sequences that overlapped portions of Areas I, II and III were expressed in 
islet cells, while longer sequences that included portions of Areas I, II and III along with less 
conserved flanking sequences recapitulated aspects of the developmental expression of Pdx1 
in foregut endoderm.  In addition, Gannon et al. showed that a transgene spanning 14.5 kb of 
the Pdx1 locus, which included the coding sequence and Areas I-IV, rescued pancreas 
development in Pdx1-/- mice.  This result suggested that most, if not all, of the critical cis-
regulatory elements are contained within this region (Gannon et al., 2001). 
 
Transactivators of Pdx1 
The transactivators known to bind the Pdx1 promoter (Fig. 1.7) can be broadly 
grouped into two categories:  factors that are expressed primarily in endocrine and neural 
tissue (Nkx2.2, Pax6, MafA and NeuroD) and factors that are widely expressed in embryonic 
endoderm (FoxA2, Hnf1α/β, and Hnf6).  While the former can account for the high level of 
expression of Pdx1 in pancreatic β cells and the latter could explain the presence of Pdx1 in 
early foregut endoderm, it remains unknown why expression of Pdx1 is much more restricted 
spatially and temporally than its FoxA/Hnf activators.  It is very likely that more trans-acting 
factors than the handful listed above are involved in regulating Pdx1, including repressors 
that may restrict the domain of Pdx1 expression within FoxA/Hnf-expressing endoderm.  It is 
also possible that the ability of FoxA/Hnf factors to bind and activate Pdx1 is modulated by 
intercellular signaling pathways.  As mentioned above, the ability of FoxA2 to activate Area 
IV in vitro was shown to be repressible by glucocorticoids (Sharma et al., 1997).  Also, 
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binding of MafA to Pdx1 appears to be inhibited by tyrosine phosphatase activity (Samaras et 
al., 2003), suggesting that transactivation of Pdx1 may be subject to extrinsic regulation. 
 
Part III -- Roles of Pdx1 in pancreas and gut development and function 
 
Transactivator function of Pdx1 
While the Pdx1 gene is a substrate for diverse regulatory interactions, the Pdx1 
protein is itself a critical transcriptional regulator involved in several developmental and 
physiological processes in the posterior foregut.  The first functions of Pdx1 to be elucidated 
were its ability to bind and transactivate the promoters of genes encoding the peptide 
hormones insulin and somatostatin (Ohlsson et al., 1993; Peers et al., 1994; Peshavaria et al., 
1994; Leonard et al., 1993; Miller et al., 1994).  Pdx1 was later shown to promote 
transcription of Glut2 and Glucokinase (Waeber et al., 1996; Watada et al., 1996), which 
encode components of the glucose-sensing machinery in pancreatic β cells.  Targeted 
inactivation of Pdx1 in mice led to the remarkable finding that, in addition to its role in 
transactivating genes in the pancreatic islets, Pdx1 is essential for formation of the pancreas 
(Jonsson et al., 1994).  Subsequent identification of a human family carrying an inactivating 
mutation in IPF1 (the human homolog of Pdx1) revealed that heterozygosity for the mutant 
allele resulted in a heritable form of early-onset type II diabetes known as maturity onset 
diabetes of the young type 4 (MODY4) (Stoffers et al., 1997a).  In humans as in mice, 
homozygosity for the mutant allele was found to result in pancreatic agenesis (Stoffers et al., 
1997b). 
 
 21 
Characterization of Pdx1-/- phenotypes 
Further studies of Pdx1-/- mice have revealed that the dorsal and ventral pancreatic 
buds form in the absence of Pdx1, but the ventral bud regresses and the dorsal bud fails to 
differentiate properly.  The rudimentary dorsal bud arrests as a duct-like cyst whose 
epithelium contains a few immature insulin- and glucagon-expressing cells, but no other 
markers of mature pancreatic cell types (Ahlgren et al., 1996; Offield et al., 1996).  These 
defects reflect an autonomous requirement for Pdx1 in the pancreatic epithelium, since 
recombination of wild-type mesenchyme with Pdx1-/- epithelium did not rescue pancreatic 
development, while Pdx1-/- mesenchyme could support the development of wild-type 
pancreatic epithelium (Ahlgren et al., 1996).   
Pdx1-/- mutants display a variety of defects in non-pancreatic tissues of the posterior 
foregut.  The rostral duodenum fails to mature properly, exhibiting a flattened cuboidal 
epithelium, very few submucosal Brunner’s glands, reduced numbers of enteroendocrine 
cells, and a malformed, stenotic gastroduodenal junction (Offield et al., 1996).  Antropyloric 
gastrin cells and duodenal GIP cells are virtually absent in Pdx1-/- mice (Larsson et al., 1996; 
Jepeal et al., 2005).  It was recently shown that the common bile duct develops abnormally in 
Pdx1-/- mutants, as characterized by malformation of the major duodenal papilla, lack of 
peribilliary glands, absence of mucin-producing cells, and formation of bile stones secondary 
to reflux of duodenal contents (Fukuda et al., 2006b).   
Haploinsufficieny for Pdx1 has also been shown to have deleterious consequences.  
Pdx1+/- mice are glucose intolerant due to impaired glucose-stimulated insulin secretion and 
have increased susceptibility to β-cell apoptosis (Brissova et al., 2002; Johnson et al., 2003). 
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Conditional inactivation of Pdx1 
To explore the roles of Pdx1 after the early patterning events for which it is required, 
two strategies have been employed to conditionally inactivate or repress expression of Pdx1.  
The first strategy was to flank the second exon with loxP sites, generating a null allele 
subsequent to “loop-out” excision of the loxP-flanked (“floxed”) sequence by Cre 
recombinase (Ahlgren et al., 1998; method reviewed by Nagy, 2000; Branda and Dymecki, 
2004).  Ahlgren et al. (1998) used a transgene to express Cre in differentiated β cells, 
showing that loss of Pdx1 from mature β cells resulted in fewer insulin-expressing cells and 
more glucagon-expressing cells per islet.  The remaining insulin-expressing cells had 
decreased levels of proteins associated with β cell maturation and function.   
The second strategy involved replacing the Pdx1 coding sequence with a gene 
encoding the tetracycline-repressible transcriptional activator tTA (Holland et al., 2002).  
Homozygosity for the knock-in allele resulted in a Pdx1 null condition that could be rescued 
by the presence of a transgene encoding Pdx1 cDNA under the regulation of a promoter that 
depends on tTA for activation.  With this elegant system in place, Pdx1 was expressed 
normally in the absence of tetracycline, but the level of Pdx1 could be rapidly reduced by 
treatment with the tetracycline analog doxycycline during embryonic development (Hale et 
al., 2005) or in adult mice (Holland et al., 2002, 2005).  These experiments revealed that 
suppression of Pdx1 production in adult mice resulted in a reversible loss of insulin 
expression in β cells and decreased expression of elastase and amylase in the exocrine 
pancreas (Holland et al., 2002, 2005).  When doxycycline was administered during 
embryogenesis, differentiation and proliferation of pancreatic endocrine and acinar cells were 
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arrested shortly after the onset of doxycycline treatment, and could recover somewhat after 
discontinuation of treatment (Hale et al., 2005). 
 
Targeted deletion of cis-regulatory regions of Pdx1 
The wealth of knowledge about the transcriptional regulation of Pdx1 and the various 
phenotypic consequences of reduced or absent Pdx1 protein has made the Pdx1 locus an 
attractive model for studying how manipulation of cis-regulatory regions affects gene 
regulatory networks in vivo.  The first study of this type involved targeted removal of a 1.2 
kb region encompassing the evolutionarily conserved Areas I, II and III (described above) 
from the endogenous Pdx1 gene (Fujitani et al., 2006).  As expected for deletion of a region 
known to have strong β-cell-specific enhancer activity, the most severely affected population 
in the enhancer-deletion mutants was the β cells.  β cells in mice heterozygous for the 
enhancer deletion (Pdx1ΔI-II-III/+) had dramatically decreased expression of Glut2 and were 
deficient in glucose-stimulated insulin secretion.  While β cells are the most abundant 
pancreatic endocrine cell (~75%) in wild-type mice, Pdx1ΔI-II-III/ΔI-II-III mice formed very few 
insulin-expressing cells.  In contrast, clusters of glucagon- and somatostatin-expressing cells 
were formed along with acinar and ductal structures that appeared to be well differentiated.   
In addition to abrogated production of β cells, Pdx1ΔI-II-III/ΔI-II-III mice had a variety of 
defects indicating that Pdx1-dependent developmental processes require different threshold 
levels of Pdx1.  For instance, a low level of Pdx1 in the early pancreatic buds was sufficient 
for outgrowth and differentiation of the dorsal bud but not the ventral bud.  The mildly 
reduced level of Pdx1 in the developing duodenum was sufficient for the normal 
 24 
differentiation of the submucosal Brunner’s glands, but resulted in an approximately 50% 
reduction in the number of GIP cells. 
The finding that the dorsal pancreatic bud of Pdx1ΔI-II-III/ΔI-II-III mice was selectively 
deficient for the production of β cells is of particular interest in light of a recent report 
showing a correlation between the timing of upregulation of Pdx1 in differentiating β cells 
and the onset of expression of MafA and other markers of β-cell maturity (Nishimura et al., 
2006).  Considering that MafA is a strong activator of the PB region of the Pdx1 promoter 
(Samaras et al., 2003), the results of Nishimura et al. suggested that MafA might trigger 
upregulation of Pdx1 (or perhaps vice versa) during differentiation of β cells from endocrine 
cell precursors.  These data led us to hypothesize that lack of the PB region in the Pdx1ΔI-II-
III/ΔI-II-III mice blocks the Pdx1 upregulation step of β cell differentiation, thereby altering the 
proportion of endocrine progenitors that develop into insulin-producing cells.   
 
Part IV -- Aims of the dissertation research 
 
 Based on the results of the past studies described above, we designed experiments to 
(1) test for an influence of cis-regulatory elements outside of Areas I, II and III on the in vivo 
expression and function of Pdx1, and (2) to assess the role of Pdx1 in cell fate determination 
of pancreatic endocrine progenitor cells.  Our strategy for the first project was to genetically 
complement Pdx1-/- mice with a transgene including Areas I, II and III and the Pdx1 coding 
region but lacking putative cis-regulatory sequences upstream of -4.5 kb.  We hoped that this 
experiment would resolve the apparent discrepancy between in vitro experiments showing 
that the distal promoter elements in the Area IV region strongly promote β-cell-specific 
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expression (Sharma et al., 1996; Sharma et al., 1997; Gerrish et al., 2004) and the in vivo 
reporter experiments (Wu et al., 1997; Stoffers et al., 1999; Gannon et al., 2001) indicating 
that all the cis-elements required to establish the Pdx1 expression domain are contained 
within the proximal 4.6 kb promoter region.  Because Gerrish et al. (2004) had recently 
shown that Area IV synergizes with Areas I and II, we hypothesized that mice expressing 
Pdx1 from the 4.6 kb promoter would have a normal pattern of Pdx1 expression but 
abnormally low levels of expression, particularly in mature β cells.  Another clue as to a 
potential role of sequences upstream of -4.5 kb was that expression of a lacZ reporter 
transgene driven by the 4.6 kb promoter resulted in surprisingly weak XGal staining in adult 
duodenal mucosa (Stoffers et al., 1999).  The results of the transgene complementation 
experiments are presented in Chapter 3. 
 For the second project, we used mice expressing Cre recombinase from regulatory 
elements of Ngn3 to recombine floxed alleles of Pdx1 in common progenitors of all four 
pancreatic endocrine lineages.  Lineage-tracing experiments and analysis of mice with 
mutations in genes encoding endocrine-specific transcription factors have led to a model of 
pancreatic endocrine differentiation where the α cell lineage is the first to lose the potential 
to give rise to the other endocrine cell types (reviewed by Wilson et al., 2003), possibly due 
to mutual inhibition between the Pax4 and Arx transcription factors (Collombat et al., 2003).  
The β, δ and PP lineages subsequently diverge through a poorly understood mechanism that 
may involve Pax4 (Collombat et al., 2005).  Because the highest level of Pdx1 expression is 
observed in β cells, a lower level is expressed in some δ cells, and there is no detectable 
expression in mature α and PP cells (Guz et al., 1995), we hypothesized that complete loss of 
Pdx1 from endocrine progenitors would impair allocation to the β and δ cell lineages, 
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whereas reduced expression of Pdx1 would inhibit generation of β cells while sparing 
production of δ cells.  Preliminary results of these experiments are described in Chapter 4. 
 Shortly before I joined the lab, a transcription factor known as Mist1 was reported to 
be expressed in the early pancreatic buds and then subsequently restricted to developing and 
mature pancreatic acinar cells (Pin et al., 2001).  This pattern of expression was strikingly 
similar to that of Ptf1a, an essential regulator of pancreatic acinar cell development that other 
members of the lab were studying at the time (e.g., Kawaguchi et al., 2002).  Despite the 
intriguing expression pattern of Mist1, Mist1-/- mutants had very mild defects in pancreas 
development (Pin et al., 2001).  We postulated that Ptf1a and Mist1 might have partially 
redundant developmental roles, and I embarked on a side project to determine if Ptf1a-;Mist1- 
compound mutants have synthetic pancreatic phenotypes.  During the course of these 
experiments, I serendipitously discovered a Ptf1a haploinsufficiency phenotype affecting the 
balance of endocrine versus exocrine pancreatic differentiation in the early pancreatic buds.  
These results are described in Chapter 5. 
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CHAPTER II 
 
MATERIALS AND METHODS 
 
Mouse strains 
The studies described in the following chapters used several transgenic and gene-targeted 
mouse strains that have been previously described.  The null alleles of Pdx1, Ptf1a, and Mist1 
are the previously characterized Pdx1XBko (Offield et al., 1996), Ptf1acre (Kawaguchi et al., 
2002), and Mist1lacZ (Pin et al., 2001) alleles.  Details of the Pdx1floxE2 allele will be provided 
in an upcoming publication from Maureen Gannon, VUMC Department of Medicine, but it is 
in most respects equivalent to the Ipf1/Pdx1-loxP allele described by Ahlgren et al. (1998).  
The other floxed alleles are Pdx1floxI-II-III (Fujitani et al., 2006) and ROSA26R (Soriano, 1999).  
Transgenic Cre-expressing lines used in Chapter 4 are Ngn3Cre (Gu et al., 2002), 
Ngn3CreBAC (Schonhoff et al., 2004b), RIPCre (Postic et al., 1999) and ElastaseCre 
(Grippo et al., 2002).  Generation of the 12.5 kb Pdx1 rescue transgene used in Chapter 3 is 
described below.  Mice were genotyped by PCR amplification of genomic DNA purified 
from tail snip digests, except for the transgene-rescue mice, which were genotyped by a 
combination of PCR and Southern hybridization strategies (described below).  All mice used 
for these experiments were maintained on a B6D2 (C57BL/6:DBA/2J) mixed-inbred 
background.  Experiments were performed in accordance with the guidelines of the 
Vanderbilt University Institutional Animal Care and Use Committee. 
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Generation of 12.5 kb rescue transgene 
To make the 12.5 kb Pdx1 transgene, the 14.5 kb genomic clone described in Offield et al. 
(1996) was digested with XbaI and BamHI to yield a fragment extending from the XbaI site 
at -4.5 kb to the first BamHI site in the intron.  The genomic clone was also digested with 
BamHI and SalI to yield a fragment extending from the second BamHI site in the intron to 
the SalI site in the 3’ λ linker.  These two fragments were ligated between the XbaI and SalI 
sites in the MCS of pBluescript KSII (Stratagene).  The resulting plasmid was digested with 
NotI and SalI and electrophoresed in a low melting temperature agarose gel to isolate the 
linear 12.5 kb transgene.  The transgene DNA was recovered by GELase (Epicentre) 
enzymatic treatment and purified by phenol/chloroform and chloroform extraction.  
Transgenic founders were generated by the Vanderbilt ES Cell/Transgenics core by injection 
of the transgene into pronuclei of fertilized B6D2 oocytes, which were then transferred to 
pseudopregnant ICR females.  F1 offspring were screened by genomic Southern blot to 
identify germline transmission of the transgene (Fig. 2.1).  Subsequent generations were 
genotyped for presence of the transgene using the same Southern hybridization strategy.  
Pdx1-/-;12.5kbTg (transgene-rescue) mice could be identified based on the lack of a 5 nt sequence 
between the paired BamHI sites in the intron of Pdx1.  This sequence is absent from the 
Pdx1XBko allele and from the rescue transgene.  Therefore, an oligonucleotide primer designed 
to match the genomic sequence spanning the paired BamHI sites annealed to the wild-type 
allele but not to the transgene or XBko.  Absence of PCR product when using this primer was 
diagnostic for mice that were homozygous for the XBko null allele regardless of presence of 
the transgene.  
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Fig. 2.1  Genotyping rescue transgene by Southern blot.  Mouse genomic DNA was 
digested overnight with EcoRI and probed with a 1.25 kb XbaI-EcoRI fragment from the 5’ 
end of the rescue transgene sequence.  The probe labels a 4.6 kb band from the endogenous 
Pdx1 locus.  The size of band labeled by the probe for the transgenic alleles depends on the 
distance to the next EcoRI site 5’ of the transgene insertion site.  For b3Tg the next EcoRI 
site is approx. 750 bp away, 750 bp + 1.25 kb = 2.0 kb.  For b1Tg the next EcoRI site is 
approx. 2.45 kb distant, 2.45 kb + 1.25 kb = 3.6 kb.  The band of approx. 1.5 kb that is 
labeled for both transgenic alleles most likely represents head-to-tail insertion of the 
transgene.  The most 3’ located EcoRI site in the transgene is 320 bp from the 3’ end. If the 
transgene is inserted head to tail, a band of 320 bp + 1.25 kb = 1.57 kb would be expected.  
Densitometric analysis of band intensity yielded average intensities of approx. 2 for the 4.6kb 
band in all lanes, 1 for the 3.6 kb band, 1 for the 2.0 kb band, 1 for the 1.5 kb band in the 
b3Tg lane and 4 for the 1.5 kb band in the b1Tg lane.  Therefore we conclude that the b3Tg 
allele consists of two copies of the rescue transgene integrated head to tail, and the b1Tg 
allele comprises 5 copies head to tail in a concatemer. 
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Whole-mount XGal staining 
LacZ reporter expression in Chapters 4 and 5 was visualized by incubation of dissected 
tissues with 5-bromo-4-chloro-3-indoly-β-D-galactopyranoside (XGal).  Tissues were fixed 
in ice-cold 4% paraformaldehyde/PBS for 1 h at 4°C, then washed in permeabilization 
solution (2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% Nonidet P-40 in PBS) for 1 h at 
room temperature, and then incubated for 12-48 h at 4°C in staining solution (2 mM MgCl2, 
5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 20 mM Tris pH 7.4, 1 mg/ml 
XGal in PBS).  After the stain had developed to the desired intensity, samples were post-
fixed in 4% paraformaldehyde/PBS for 3-5 h at 4°C, and then embedded and sectioned as 
described below. 
 
Whole-mount IHC 
Dissected tissues were fixed overnight at 4°C in 4:1 CH3OH/DMSO, rehydrated in 1:1 
CH3OH:PBS followed by PBS, and then blocked with two 1 hour incubations in PBSMT 
(2% dried nonfat milk, 0.5% Triton X-100 in PBS).  Samples were incubated overnight at 
4°C with the first primary antibody, guinea-pig anti-glucagon (Linco), diluted 1/2000 in 
PBSMT.  The next day, samples were washed in PBST (0.5% Triton X-100 in PBS) three 
times for 1 h each and then incubated overnight with the next primary antibody, rabbit anti-
Mist1 (gift of S. Konieczny, Purdue University), diluted 1/1000 in PBSMT.  The wash and 
incubation steps were repeated for the secondary antibodies, Cy2-conjugated donkey anti-
guinea pig (1/500) and Cy3-conjugated donkey anti-rabbit (1/500).  After the final secondary 
antibody incubation and subsequent washes in PBST, the samples were dehydrates through a 
series of 50%, 80% and 100% CH3OH.  Prior to visualization, the stained samples were 
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cleared in BABB (1:2 benzyl alcohol:benzyl benzoate) for 5 min.  3D projections of confocal 
z-stacks of the stained tissues were obtained using a Zeiss LSM510 confocal microscope and 
the included software. 
 
Histology 
Dissected tissues were fixed in 4% paraformaldehyde/PBS for 3-5 h at 4°C (1 h for E12.5 
embryos).  After fixation, tissues were dehydrated in increasing concentrations of ethanol, 
washed into Histo-Clear (National Diagnostics) and embedded in paraffin.  5-µm sections 
were cut using a Leica RM2135 microtome.  PAS staining was performed using reagents and 
protocol from Sigma.  After staining with Schiff’s reagent, samples were washed briefly in 
10% sodium metabisulfite to reduce background.  Hematoxylin (Zymed) counterstain was 
applied for 30-90 seconds depending on desired intensity of stain, followed by thorough 
rinsing in deionized tap water.   
 Immunoperoxidase staining used the Vectastain ABC and DAB kits (Vector 
Laboratories).  The provided secondary antibodies were applied at 1/1000 dilution for 1 h at 
room temperature.  For immunoperoxidase-DAB staining, primary antibodies were incubated 
overnight at 4°C at the indicated dilutions: rabbit anti-Gastrin (1/1000, Research 
Diagnostics), rabbit anti-GIP (1/5000, Research Diagnostics), rabbit anti-CCK (1/2000, 
Peninsula/Bachem), rabbit anti-Somatostatin (1/2000, Dako), rabbit anti-ChormograninA/B 
(1/500, Abcam), guinea-pig anti-Insulin (1/5000, Linco), rabbit anti-glucagon (1/20,000, 
Linco) and guinea pig anti-Pdx1 (1/7500, generated by Strategic Biosolutions from a fusion 
protein made in our lab, which consisted of GST plus the N-terminal 75 amino acids of 
mouse Pdx1).  Dilutions were made in 5% normal donkey serum/PBS, which was also used 
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as a blocking reagent.  Prior to addition of anti-Pdx1 antibody, antigen retrieval was 
performed by heating slides to 95°C for 10 min in 10 mM sodium citrate, pH 6.0.   
 Immunofluorescence staining used the following primary antibodies and dilutions: 
rabbit anti-Glucagon (1/2000, Linco), guinea pig anti-Insulin (1/1000, Linco), rabbit anti-
Somatostatin (1/1000, Dako), guinea pig anti-PP (1/750, Linco), goat anti-Pdx1 (1/2000, 
generated by Strategic Biosolutions from our GST-Pdx1 fusion protein) guinea pig anti-Pdx1 
(1:5000), goat anti-Villin (1/100, Santa Cruz), rabbit anti-GIP (1/500, Research Diagnostics), 
rabbit anti-ChromograninA/B (1/200, Abcam), goat anti-Insulin C-peptide (1/5000, Linco), 
rabbit anti-human Amylase (1/500, Sigma), rabbit anti-Mist1 (1/10,000, gift of S. Konieczny, 
Purdue University), and mouse anti-Ngn3 (1/10,000, gift of Palle Serup, Hagedorn Research 
Institute, Denmark).  Secondary antibodies were incubated for 2 h at room temperature at the 
indicated dilutions: donkey anti-goat-Cy5 (1/500, Jackson Immuno), donkey anti-rabbit-Cy3 
(1/500, Jackson Immuno), donkey anti-guinea-pig-Cy2 (1/250, Jackson Immuno).  5% 
normal donkey serum/PBS was used to dilute antibodies and for blocking.  Secondary 
detection of Villin, Ngn3, Mist1 and guinea pig anti-Pdx1 was by Vectastain ABC kit 
(Vector) followed by TSA-Fluoroscein reagent (1/100, Perkin-Elmer) or TSA-Cyanine 
reagent (1/200, Perkin-Elmer) for 20 min at room temperature.  When TSA was used for 
amplification, blocking and primary antibody dilutions utilized Perkin-Elmer blocking 
reagent.  Secondary detection of GIP and chromogranins was by goat anti-rabbit-biotin 
(1/1000, Vector) for 1 h followed by Cy3-Streptavidin (1/500, Jackson Immuno) for 2 h at 
room temperature.  Villin-stained sections were counterstained with YoPro-1 (1/1000, 
Molecular Probes) for 20 min to label nuclei.  Pdx1 and Mist1 antigens were retrieved by 
heating slides to 95°C for 10 min in 10 mM sodium citrate pH 6.0 (for Pdx1) or 100 mM Tris 
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pH 10.0 (for Mist1).  All fluorescently labeled slides were mounted with ProLong Anti-fade 
Gold reagent (Molecular Probes/Invitrogen). 
 
Western blotting and quantification 
Whole-pancreas nuclear extract was recovered as previously described (Gannon et al., 2001).  
10 mg of sample per lane was run on pre-cast NuPAGE 10% Bis-Tris gels (Invitrogen) in 
MES buffer and transferred to Immobilon –P PVDF membranes (Millipore).  Membranes 
were blocked for 1 h at room temperature in TBSMT (Tris-buffered saline, 5% dried nonfat 
milk, 0.1% Tween-20) and incubated overnight at 4°C with primary antibody solution 
(1/2000 rabbit anti-Pdx1 (Peshavaria et al., 1994), 1/10,000 rabbit anti-Histone 2B (Sigma) 
in TBSMT).  Membranes were washed 5 times in TBST and then incubated in secondary 
antibody solution (1/2000 goat anti-rabbit-HRP, Santa Cruz Biotech) for 1 h at room 
temperature, followed by 5 more TBST washes.  Membranes were incubated in SuperSignal 
West Pico Chemiluminescent Substrate (Pierce) for 5 min and then visualized using the 
BioRad Chemidoc imaging system and Quantity One software (BioRad).  Images were 
captured at 30 sec intervals for 20 min to determine optimum exposure.  Integrated intensity 
of bands was measured and corrected for background using Quantity One software.  
Integrated intensity of the Pdx1 band was divided by the integrated intensity of the Histone 
2B band for each lane.  One of the Pdx1+/- samples was selected to be loaded on every gel to 
ensure that relative signal intensities were equivalent from blot to blot. 
 
 35 
Intraperitoneal glucose tolerance test 
Following a 16-h fast, dextrose (2 mg/g body weight) was injected intraperitoneally in the 
right lower quadrant.  Blood glucose was measured at 0, 15, 30, 60, 90 and 120 min after 
injection using a BD Logic glucose monitor (Becton Dickinson). 
 
Quantification of duodenal enteroendocrine cells 
P7 mice were sacrificed and the gut tube was cut through the body of the stomach superiorly 
and at the junction of the duodenum and jejunum inferiorly.  The dissected tissue was fixed 
and embedded as described above.  5-µm sections were cut parallel to the long axis of the 
duodenum.  For each sample, 5 groups of 3 adjacent sections were chosen based on roughly 
equal spacing across the diameter of the duodenum, and were immunostained for GIP, 
gastrin and CCK.  Stained sections were photographed at 20X magnification resulting in 
images of 450 x 340 µm microscopic fields.  For each section, five fields evenly spaced 
between the gastroduodenal junction and the base of the first loop of the duodenum were 
selected for quantification.  DAB-stained cells were counted manually.  Hematoxylin-stained 
nuclei were counted using Metamorph software (Molecular Devices) with manually set 
boundaries to restrict the count to villus epithelium.  For each mouse, the total number of 
hormone-positive cells was divided by the total number of villus epithelial cell nuclei to 
determine the frequency of GIP-, gastrin- and CCK-expressing cells. 
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Microscopy 
Brightfield images were photographed using an Olympus DP-70 digital camera and Olympus 
BH-2 compound microscope.  Fluorescent images were captured using a Zeiss LSM 510 
Meta confocal microscope. 
 
Statistics 
Sample means for pancreatic nuclear Pdx1 level and enteroendocrine cell frequency were 
compared by two-tailed, unpaired Student’s t-test assuming unequal variance.  The null 
hypothesis was rejected for P < 0.05. 
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 CHAPTER III 
 
COMPLEMENTATION RESCUE OF PDX1 NULL PHENOTYPE DEMONSTRATES 
DISTINCT ROLES OF PROXIMAL AND DISTAL CIS-REGULATORY SEQUENCES IN 
PANCREATIC AND DUODENAL EXPRESSION 
 
Introduction 
The homeodomain transcription factor Pancreatic and duodenal homeobox factor 1 
(Pdx1) has been a focus of research in the fields of developmental biology and endocrinology 
for more than a decade because of its essential role in pancreas morphogenesis and 
involvement in heritable Type II diabetes (reviewed by McKinnon and Docherty, 2001; 
Melloul, 2004; Melloul et al., 2002). Pdx1 is first detectable only in the nascent pancreatic 
buds, but its expression very rapidly expands to include the epithelial progenitors of the 
antrum and pylorus of the stomach, the rostral duodenum, and the common bile duct (Guz et 
al., 1995; Offield et al., 1996).  Pdx1 expression persists in all of these organs in the adult, 
although at lower levels than during embryogenesis.  While it is also expressed at low levels 
in mature pancreatic acini and a subset of the duct cells, Pdx1 continues to be highly 
expressed in pancreatic β cells and is required for their function and maintenance in adult 
animals (Ahlgren et al., 1998; Holland et al., 2005; Holland et al., 2002).   
Pdx1-/- mice do not form any mature pancreatic tissue, although a few glucagon-
expressing cells can be found in a poorly differentiated cyst-like rudiment that evaginates 
from the duodenum (Ahlgren et al., 1996; Jonsson et al., 1994; Offield et al., 1996).  The 
pancreas is the most severely affected organ in Pdx1-/- mice, but abnormalities are present in 
all of the organs that normally express Pdx1.  Defects in the stomach include drastic 
reduction in the number of gastrin-producing enteroendocrine cells (Larsson et al., 1996) and 
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malformation of the gastroduodenal junction, which is characterized by an abnormal 
transition between gastric and duodenal epithelia and malformation of the pyloric sphincter, 
often leading to pyloric stenosis and stomach dilation (Offield et al., 1996).  The rostral 
duodenum forms very few, if any, submucosal Brunner’s glands, contains reduced numbers 
of glucose-dependent insulinotropic polypeptide (GIP)-, secretin- and cholecystokinin 
(CCK)-expressing enteroendocrine cells, has shorter and sparser villus structures, and lacks a 
functional sphincter of Oddi, resulting in reflux from the duodenum into the common bile 
duct (Fukuda et al., 2006; Jepeal et al., 2005; Offield et al., 1996).  The common bile duct is 
deficient in formation of peribiliary glands and mucin-producing cells (Fukuda et al., 2006). 
Pdx1+/- mice have abrogated insulin secretion in response to glucose, presumably 
because of the reduced expression of Pdx1 target genes including Glucokinase, Glucose 
transporter 2 (Glut2) and Insulin (Brissova et al., 2002).  Humans who are heterozygous for 
inactivating mutations in IPF1 (Insulin Promoter Factor 1, the human homolog of Pdx1) 
develop a heritable form of strong early-onset Type II diabetes known as Maturity Onset 
Diabetes of the Young (MODY) Type 4 (Stoffers et al., 1998; Stoffers et al., 1997a).  In 
addition to IPF1/Pdx1 itself, mutations in MODY families have been mapped to genes 
encoding transactivators of the Pdx1 gene, Hnf1α, Hnf1β, and NeuroD1/Beta2, as well as to 
Glucokinase and Hnf4α, which are transcriptional targets of Pdx1 (reviewed by Bell and 
Polonsky, 2001; Shih and Stoffel, 2001).  
The essential roles of Pdx1 in glucose homeostasis and endoderm patterning have 
prompted great interest in understanding the regulation of Pdx1 transcription. There is still a 
very poor understanding of the interplay of inter- and intra-cellular factors in driving 
pancreatic differentiation.  Pdx1 provides a valuable entry point into dissecting these 
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processes because of its early, specific expression in the pancreas and its critical roles in 
promoting pancreatic differentiation.  Pdx1 has a TATA-less promoter and transcription can 
initiate from multiple sites ranging from approximately 90 to 130 bp upstream of the 
translational start codon (Sharma et al., 1996).  In keeping with precedent, we refer to 91 bp 
upstream of the translational start codon as the +1 position.  Promoter-deletion studies and 
DNase hypersensitivity analysis led to the identification of proximal (-2.6kb — -1.9kb in 
mouse) and distal (-5.67kb — -6.2kb in rat) enhancer sequences in the 5′ region of the rodent 
Pdx1 locus (Sharma et al., 1997; Sharma et al., 1996; Wu et al., 1997).  Sequence alignment 
between mouse and human revealed three highly conserved areas in the proximal enhancer 
region, referred to as Areas I, II and III (Gerrish et al., 2000; Marshak et al., 2000), as well as 
a more distal block of conservation (Area IV) (Gerrish et al., 2004).  Electrophoretic 
Mobility Shift Assays (EMSA) and Chromatin Immunoprecipitation (ChIP) have confirmed 
binding of several endoderm or endocrine cell enriched transactivating factors to these areas: 
Foxa2 (Areas I, II and IV), Hnf6 (I and III), Hnf1 (I), L-Maf (II), Nkx2.2 (I and IV), Pax6 
(II) and Pdx1 itself (I and IV) (Ben-Shushan et al., 2001; Gerrish et al., 2001; Gerrish et al., 
2000; Gerrish et al., 2004; Jacquemin et al., 2003; Marshak et al., 2000; Samaras et al., 2002; 
Samaras et al., 2003; Sharma et al., 1997; Van Velkinburgh et al., 2005; Wu et al., 1997). 
Reporter gene expression in transgenic mice has shown that Area II can promote 
expression specifically in β cells, and that this effect is more robust in combination with Area 
I (Samaras et al., 2002; Van Velkinburgh et al., 2005).  Longer genomic sequences 
overlapping Areas I, II and III promote expression in the pancreas and duodenum (Gannon et 
al., 2001; Stoffers et al., 1999), although expression in the duodenum appears to be limited to 
the crypts (Stoffers et al., 1999), which contain progenitors for all of the duodenal epithelial 
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cell types.  Area IV has not yet been shown to be sufficient to promote tissue-specific gene 
expression in vivo, but in vitro evidence in cell lines suggests that it promotes β-cell-specific 
transcriptional activation synergistically with Areas I and II (Gerrish et al., 2004).   
The collective influence of Areas I, II and III was recently evaluated in vivo by 
targeted deletion of the 1.2 kb of sequence encompassing these three areas (referred to as 
Area I-II-III) (Fujitani et al., 2006).  Deletion of Area I-II-III from both alleles of Pdx1 
severely disrupted pancreas morphogenesis, but the only extra-pancreatic abnormality that 
was observed was a 50% reduction in stomach gastrin cells and duodenal GIP cells.  
Correspondingly, reduction in Pdx1 protein expression was more extreme in the pancreas 
than in the stomach and duodenum.  These results demonstrated the necessity of Area I-II-III 
for pancreas development and robust expression of Pdx1, but did not test if Area I-II-III is 
sufficient to establish the correct spatiotemporal expression of Pdx1. 
To test the sufficiency of proximal cis-elements for correct regulation of Pdx1 
transcription, we used a transgene containing the Pdx1 coding region and proximal 
regulatory regions to attempt to rescue the pancreatic, stomach and duodenal phenotypes in 
Pdx1-/- mice.  A previous study demonstrated rescue of the pancreatic phenotype of Pdx1-/- 
mice using a transgene that included sequences extending 5′ through Area IV, but the extra-
pancreatic expression and activity of Pdx1 was not examined in that study (Gannon et al., 
2001).  For the current study, Area IV sequence was excluded from the rescue transgene to 
test for distinct roles of proximal and distal promoter elements, and the ability of the 
transgene to rescue pancreatic and extra-pancreatic Pdx1 expression and activity was 
evaluated.  We carried out a detailed analysis of Pdx1 distribution and levels from E12.5 
through 8 months of age, and examined the influence of a spectrum of Pdx1 gene dosages on 
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glucose tolerance and enteroendocrine cell number.  We find that expression of Pdx1 
encoded by the transgene is sufficient to rescue pancreas morphogenesis and function, but 
that the transgene does not support normal levels of extra-pancreatic Pdx1 expression.  Pdx1 
expression from the transgene was particularly weak in postnatal duodenum, and was 
associated with a 90% reduction in the number of GIP-expressing cells without other evident 
defects in morphology or differentiation of the duodenum.   
 
Results 
 
Construction of Pdx1 transgene lacking distal regulatory elements 
A 14.5 kb region of the Pdx1 locus was previously isolated from a lambda phage 
mouse genomic library (Fig. 3.1A; Offield et al., 1996).  The fragment includes 6.4 kb of 
sequence 5′ of the transcription start site and 3 kb extending 3′ of the stop codon.  Breeding 
of transgenic mice carrying this 14.5 kb region showed its sufficiency in rescuing pancreas 
formation and glucose homeostasis in mice that were homozygous null at the endogenous 
Pdx1 locus (Gannon et al., 2001).  To investigate the regulatory influence of Area I-II-III 
independent of Area IV, we tested if excluding Area IV from the transgene would affect its 
ability to rescue the foregut organogenesis defects in Pdx1-/- mice.  We removed sequences 5′ 
of an XbaI site located approximately 4.5 kb upstream of the transcription start site, 
producing a transgene that extended from 1.7 kb 5′ of Area I-II-III to 3 kb 3′ of the stop 
codon (Fig. 3.1A).  Three F1 mice tested positive for this 12.5 kb transgene by genomic 
Southern analysis.  Independent transgenic lines were established and bred onto a Pdx1-/- 
background.  Two of the three lines rescued pancreas formation.  The third line generated  
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Fig. 3.1  12.5 kb transgene rescues pancreas formation in Pdx1-/- mice.  (A)
Schematic of Pdx1 genomic region.  Non-coding sequences >100 bp with >75%
human-to-mouse conservation are indicated by colored boxes (I-IV) after Gerrish et
al. (2000).  The transgene used for genetic complementation extended from an XbaI
site 4.5 kb 5’ of the transcription start site to a SalI site introduced 3 kb 3’ of the stop
codon.  Restriction sites shown are EcoRV (RV), XbaI (X), PstI (P), BstEII (Bs), SacI
(Sc), BamHI (B), SmaI (Sm), SalI (S).  (B – D) Dissected and fixed stomach (sto),
spleen (spl), pancreas (panc) and first duodenal loop (duo) of newborn (P0) mice.  (C)
No mature pancreatic tissue was present in Pdx1-/- pups.  (D) Complementation of
Pdx1-/- with 12.5 kb transgene rescued the formation of pancreas grossly
indistinguishable from wild type.
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a slightly thicker pancreatic rudiment than was seen in Pdx1-/- littermates, but Pdx1 was not 
detectable by immunohistochemistry at postnatal day 6 (P6) in this line (data not shown).  
Southern analysis indicated that both of the rescuing lines contained single-site insertions of 
the transgene.  One line (referred to hereafter as b1Tg) contained approximately 5 copies of 
the transgene in a concatemer, while the other (b3Tg) had 2 copies inserted head-to-tail (see 
Fig. 2.1).  
 
Transgene complementation of Pdx1-/- rescues pancreas morphology and function 
For both active transgenic lines, the rescued pancreas (Pdx1-/-;Tg) was equivalent in 
size and gross morphology to wild type (Fig. 3.1B,D).  Histological analysis indicated that 
the organization and differentiation of acinar, duct and endocrine pancreatic tissues were 
very similar between wild-type and transgene-rescue mice (Fig. 3.2A-F).  
Immunohistochemical staining for Pdx1 revealed that its expression was higher than normal 
in acinar cell nuclei of both transgenic lines, although the intensity of staining was still much 
higher in islets than in acinar cells (Fig. 3.2G-I).  Anti-Pdx1 staining appeared to be slightly 
weaker than wild type in the islets of Pdx1-/-;b3Tg mice and slightly stronger than wild type in 
Pdx1-/-;b1Tg.   
Because previous studies have shown that perturbation of Pdx1 expression affects the 
composition and architecture of the islets (Ahlgren et al., 1998; Fujitani et al., 2006; Johnson 
et al., 2003), we examined the expression of Pdx1 and the islet hormones at 3 months (Fig. 
3.3) and 8 months (not shown) of age.  Some islets in Pdx1+/- mice showed modest 
infiltration of glucagon-producing cells into the interior (Fig. 3.3B) and co-expression of 
somatostatin and pancreatic polypeptide (PP) (yellow cells, Fig. 3.3E).  These abnormalities  
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Fig. 3.2  Pancreatic tissue of transgene-rescue mice is well differentiated.  (A – C)
Sections of splenic lobe of pancreas were stained for insulin and glucagon (brown)
and counterstained with hematoxylin (purple), showing similar structure and
distribution of endocrine and exocrine pancreatic components in transgene-rescue and
wild-type mice.  (D – F) Labeling of acinar tissue for amylase (blue) and ducts by
DBA-lectin (red) indicated that these structures were properly differentiated in
transgene-rescue mice.  Islets were visualized by anti-Pdx1 labeling (green).  (G – I)
Staining for Pdx1 (brown) indicated similar expression in the islets of wild-type and
transgene-rescue mice, but abnormally high expression in acinar cell nuclei in both
transgenic lines.  Tissues from 1-week-old mice.  Scale bars 100 µm.
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Pdx1+/+ Pdx1+/- Pdx1-/-;b3Tg
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D E F
Fig. 3.3  Normal islet morphology in transgene-rescue mice.  (A – C) Confocal
immunofluorescence analysis for Insulin (green), Glucagon (red) and Pdx1 (blue).  (D
– F) Sections adjacent to (A-C) were analyzed for PP (green), Somatostatin (red) and
Pdx1 (blue).  (A,D) Stereotypical wild-type islet structure: core β cells surrounded by
mantle of α, δ and PP cells.  Nuclear Pdx1 was observed in all β cells and most δ
cells, but very rarely in α or PP cells.  (B,E) Islets from Pdx1+/- mice tended to contain
more α cells, which were often located more centrally in the islets.  (C,F) Islets from
transgene rescue mice contained normal numbers and spatial organization of
endocrine cells.  A few α and PP cells showed weak nuclear Pdx1 immunoreactivity
(arrowheads).  Although the islet sections shown in (C,F) have more α, δ, and PP cells
than (A,D), there was no consistent difference in islet composition between transgene-
rescue and wild-type mice.  Tissues from 3-month-old mice.  Scale bar in (F) is 50 µ
m.  All panels 250X magnification.
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were not found in Pdx1-/-;Tg mice (Fig. 3.3C,F), nor in Pdx1+/-;Tg mice (not shown).  The only 
apparent difference between wild-type and transgenic islets was that we observed co-
expression of Pdx1 with glucagon or PP in a few cells of each transgenic islet examined (Fig. 
3.3C,F, white arrowheads), while co-expressing cells were not evident in most wild-type 
islets.  Co-expression of Pdx1 with glucagon and PP was also seen in Pdx1+/+;Tg and Pdx1+/-
;Tg mice (not shown).  These results suggest that regulatory elements missing from the 
transgene may help to repress the expression of Pdx1 in mature glucagon-producing (α) and 
PP cells.  Induction of insulin expression was not observed in the α cells that ectopically 
expressed Pdx1. 
To assess the function of the rescued islets, mice were subjected to intraperitoneal 
glucose tolerance testing (IPGTT) using wild-type littermates as controls.  In agreement with 
previous reports (Brissova et al., 2002; Dutta et al., 1998; Johnson et al., 2003), Pdx1+/- mice 
at 5-6 weeks and 5 months of age experienced higher peak blood glucose levels and slower 
glucose clearance than wild-type littermates (Fig. 3.4A,B).  Presence of b3Tg (Fig. 3.4A) or 
b1Tg (Fig. 3.4B) restored wild-type glucose tolerance to Pdx1+/- mice, but Pdx1-/-;Tg mice 
displayed intermediate glucose clearance curves between wild type and Pdx1+/-.  
 
Pdx1-/-;b1Tg mice are glucose intolerant despite abundant Pdx1 protein 
Several studies have shown a correlation between reduced Pdx1 expression and 
glucose intolerance (e.g., Ahlgren et al., 1998; Brissova et al., 2002; Gannon et al., 2001; 
Holland et al., 2005; Holland et al., 2002).  We postulated, therefore, that the intermediate 
IPGTT performance of Pdx1-/-;Tg animals corresponded to an intermediate level of Pdx1 
protein in the pancreas.  Based on immunohistochemical analysis (Fig. 3.2G-I), the level of  
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Fig. 3.4  Comparison of IPGTT and pancreatic Pdx1 content among offspring of Pdx1+/-
;Tg parents.  (A) Offspring of Pdx1+/-;b3Tg mice; 5 litters of 5-6 weeks of age. Glucose 
tolerance of Pdx1+/- mice (white) was impaired compared to wild type (black).  Pdx1-/-;b3Tg 
(yellow) had a mild impairment, while glucose tolerance of Pdx1+/-;b3Tg (orange) and 
Pdx1+/+;b3Tg (red) was normal.  Number of each genotype: wild type (5), Pdx1+/- (10), 
Pdx1+/+;b3Tg (2), Pdx1+/-;b3Tg (10), Pdx1-/-;b3Tg (8).  (B) Offspring of Pdx1+/-;b1Tg mice; 4 litters, 
5 months of age.  Glucose tolerance of Pdx1-/-;b1Tg mice (green) was intermediate between 
wild type (black) and Pdx1+/- (white).  Pdx1+/-;b1Tg (purple) and Pdx1+/+;b1Tg (blue) were 
similar to wild type.  Glucose tolerance for mice in (B) was generally worse than in (A) 
because of age.  Number of each genotype: wild type (2), Pdx1+/- (11), Pdx1+/+;b1Tg (4), 
Pdx1+/-;b1Tg (9), Pdx1-/-;b1Tg (4).  (C) Nuclear proteins from whole pancreas of 3-month-old 
mice (genotype indicated; color coding as for A and B).  Relative Pdx1 level was determined 
based on western blot signal intensity with the average wild-type value set as “1”.  Anti-
histone 2B immunoreactivity, loading control. P < 0.05 for Pdx1+/- versus all other 
genotypes.  P < 0.05 for wild type versus all genotypes except Pdx1+/+;b3Tg.  Number of each 
genotype: wild type (8), Pdx1+/- (9), Pdx1+/+;b3Tg (3), Pdx1+/-;b3Tg (6), Pdx1-/-;b3Tg (6), 
Pdx1+/+;b1Tg (5), Pdx1+/-;b1Tg (6), Pdx1-/-;b1Tg (4).  Error bars in (A-C) indicate +/- SEM. 
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Pdx1 protein in islets of Pdx1-/-;b3Tg mice appeared to be slightly lower than wild type, while 
that in Pdx1-/-;b1Tg mice was slightly higher than wild type.  To obtain a more quantitative 
assessment of the level of Pdx1 expression in the transgene-rescue mice, we measured the 
amount of Pdx1 protein in pancreatic extracts by densitometric analysis of western blots.  By 
normalizing band intensity to that of a constitutively expressed nuclear protein, histone 2B, 
we calculated the amount of nuclear Pdx1 in heterozygotes to be approximately 43% of wild-
type levels in 3-month-old littermates (Fig. 3.4C).  Western blot analysis of b3Tg yielded 
results consistent with our prediction: the Pdx1-/-;b3Tg mice had protein levels between Pdx1+/- 
and wild type (~56% of wild type).  However, the level of Pdx1 was at least twice that of 
wild type for all mice carrying b1Tg (Fig. 3.4C).  Overexpression in acinar tissue may have 
contributed to the high level of Pdx1 in b1Tg mice, but the level of Pdx1 in the islets of Pdx1-
/-;b1Tg was also higher than in wild-type mice (Fig. 3.2).  It seems unlikely, therefore, that 
glucose intolerance in Pdx1-/-;b1Tg mice resulted from an insufficient level of Pdx1 in mature 
β cells.  In addition, the lack of glucose intolerance in Pdx1+/-;b1Tg mice suggested that 
overexpression of Pdx1 in acinar, α, and PP cells did not significantly impair islet function.  
We have yet to decipher the underlying cause of glucose intolerance in the transgene-rescue 
mice, but reduced production of duodenal incretins, or minor perturbation of islet 
development, may be contributing factors (see Discussion). 
 
Pdx1 expression selectively reduced in postnatal duodenum and stomach  
We next characterized the developmental time-course of Pdx1 expression from b1Tg 
and b3Tg to determine whether proximal regulatory regions were sufficient for normal 
spatiotemporal expression of Pdx1 during development.  Breeding the 12.5 kb transgene onto 
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a Pdx1-/- background (the “XBko” allele (Offield et al., 1996) from which no protein product 
is detectable, e.g., Fig. 3.7D) ensured that the only Pdx1 protein detected was transgene-
encoded.  No consistent differences in Pdx1 expression were observed after side-by-side 
preparation and staining of tissues from wild-type and Pdx1-/-;Tg embryos from E12.5 and 
E16.5 (Fig. 3.5A,B,D,E), indicating that relatively proximal sequences are indeed sufficient 
to mediate the proper timing and distribution of embryonic Pdx1 expression.  In addition, 
immunostaining for glucagon, insulin and amylase indicated that pancreatic tissues were 
properly differentiated in transgene-rescue embryos at these stages (Fig. 3.6). 
In contrast to the normal spatiotemporal expression observed during embryogenesis, 
the 12.5 kb transgene was not sufficient for normal levels of expression in postnatal 
duodenum.  In neonatal (P0) mice, expression of Pdx1 was much weaker in the duodenal 
epithelium of Pdx1-/-;Tg mice as compared to wild-type littermates, but pancreatic expression 
was not appreciably different (Fig. 3.5C,F).  Reduced duodenal Pdx1 expression was 
observed in both transgenic lines and persisted throughout adulthood (Fig. 3.5G-N), although 
the level of transgenic Pdx1 expression was consistently lower in b3Tg than in b1Tg mice 
(cf. Fig. 3.5J,M).  Pdx1 expression was not substantially reduced in the submucosal 
Brunner’s glands that cuff the rostral-most portion of the duodenum (Fig. 3.5H,K).   
Pdx1 immunoreactivity was substantially weaker than wild-type or Pdx1+/- levels in 
the mucosal epithelium of all Pdx1-/-;Tg duodena examined from both transgenic lines.  There 
was, however, some variability in the level and pattern of duodenal Pdx1 expression among 
transgene-rescue mice of identical genotype.  Also, most of the Pdx1-/-;Tg mice from both 
lines showed a variable intensity of Pdx1 staining along the duodenal epithelium.  In general, 
Pdx1 was more strongly expressed in crypts than in villi (e.g., Fig. 3.5J), although  
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Fig. 3.5  Developmental profile of Pdx1 expression in Pdx1-/-;Tg compared to wild type.  
(A,B,D,E) Pdx1 expression in Pdx1-/-;Tg was similar to wild type during embryonic stages.  
The extent of expression in the stomach appeared to be reduced in Pdx1-/-;Tg at E12.5, but this 
may be an artifact due to the plane of section.  No difference in expression in the stomach 
was seen at E16.5.  Representative sections, Pdx1-/-;b1Tg at e12.5 (D) and Pdx1-/-;b3Tg at e16.5 
(E).  VP, ventral pancreatic bud; DP, dorsal pancreatic bud; Du, duodenum; St, stomach; Pa, 
pancreas.  (C,F) After birth, reduced Pdx1 immunoreactivity was observed in Pdx1-/-;Tg 
duodena (Pdx1-/-;b3Tg shown in F).  (G – M) Duodenal Pdx1 expression continued to be 
substantially lower in Pdx1-/-;Tg postnatally.  Representative sections: Pdx1-/-;b1Tg (J) and 
Pdx1-/-;b3Tg (K,L,M).  (G, J, M, N) One week of age.  Duodenal Pdx1 expression was weaker 
in Pdx1-/-;b3Tg (M) than in Pdx1-/-;b1Tg (J).  Both were much weaker than Pdx1+/- (N) or wild 
type (G).  The intensity of Pdx1 staining in pancreatic tissue was similar among the different 
genotypes.  (H,K) 3 months of age, sections of duodenum near the gastroduodenal junction 
showed Pdx1 expression in Pdx1-/-;Tg that was relatively well-preserved in Brunner’s glands 
(Br), variable in crypts (Cr) and weakest in villi (Vi).  Insets in (H,K), higher magnification 
of Pdx1+ nuclei in Brunner’s glands.  All tissues from each stage were processed, stained and 
photographed side-by-side under the same conditions.  Dotted outlines in (F,G,J,N) indicate 
islet tissue.  Scale bars 200 µm.  Panels (B,E) 20X magnification; all others 55X. 
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Fig. 3.6  Pancreatic buds of transgene-rescue embryos were properly
differentiated at E12.5 and E16.5.  Upper panels, similar numbers of glucagon-
expressing cells were detected in the ventral (VP) and dorsal (DP) pancreatic buds at
E12.5 in wild-type and transgene-rescue mice.  Lower panels, the pancreatic buds of
transgene-rescue mice appeared to be appropriately differentiated at E16.5 based on
expression of amylase (green) and endocrine hormones (red, insulin and glucagon).
Nuclei of pancreatic epithelial cells were labeled for Pdx1 (blue). Scale bars 50 µm.
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the level of expression varied among neighboring crypts (e.g., Fig. 3.5K, Fig. 3.12C).  
Ribbons of relatively high-expressing cells were frequently observed extending up the 
proximal villi associated with the more strongly expressing crypts, consistent with the 
progenitor-daughter relationship between the surrounding crypts and their derived villus 
epithelial cells.  In wild type and Pdx1+/- mice, Pdx1 appeared to be expressed at equal levels 
in all crypts and villi of the rostral portion of the duodenum, although the intensity of 
immunostaining often appeared stronger at the bases of the villi than at their tips.  We 
hypothesize that a variegated expression pattern is observed in Pdx1-/-;Tg duodenal epithelium 
because an abnormally low level of Pdx1 transcription in postnatal crypt stem cells 
exacerbates the influence of stochastic transcriptional activation (i.e., “transcriptional 
noise”).  This leads to the production of a low, but variable, level of Pdx1 protein in basal 
enterocytes that is gradually lost as they ascend the villi.   
 The 12.5 kb transgene also failed to provide full expression of Pdx1 in the 
antropyloric mucosa of the postnatal stomach (Fig. 3.7A-D).  Detection of Pdx1 was rather 
weak even in wild-type stomach at P7 but was more readily detected at 3 months of age, at 
which time the difference in immunoreactivity between wild type and Pdx1-/-;b3Tg was more 
pronounced (Fig. 3.8A,B).  In wild-type P7 mice, Pdx1 was detectable in all antropyloric 
epithelial cells with scattered cells staining much more intensely for Pdx1 (Fig. 3.7A).  In 
Pdx1-/-;b1Tg mice, the scattered high-expressing cells were still readily detected, but the 
overall level of Pdx1 appeared to be lower (Fig. 3.7B).  As in the pancreas and duodenum, 
the level of expression from b3Tg was less than from b1Tg.  Although scattered cells in 
Pdx1-/-;b3Tg stomach had higher levels of Pdx1 expression, their immunostaining intensity  
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Fig. 3.7  Concordant reduction in Pdx1 and gastrin in stomach at P7.  (A – D) 
Immunoperoxidase staining for Pdx1 in the antropyloric mucosa showed progressive 
reduction in intensity from wild type to Pdx1-/-;b1Tg to Pdx1-/-;b3Tg, and no staining in Pdx1-/-.  
(E – H) Frequency of gastrin-immunopositive cells (brown) showed a similar correlation to 
genotype.  Immunoperoxidase-DAB, hematoxylin counterstain.  Scale bars 100 µm.  All 
panels 150X magnification. 
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Fig. 3.8  Antral mucosa of stomach was labeled for Pdx1 at 3 mo and somatostatin at 
P7.  (A) In antral mucosa of wild-type mice, Pdx1 staining was most intense in the pits and 
was detectable in all epithelial cell nuclei.  (B) In Pdx1-/-;b3Tg mice at 3-months-of-age, Pdx1 
staining of variable intensity was detected in the antral pits, and Pdx1 staining was not 
evident in the upper portion of the glands.  (C,F) As previously reported, somatostatin-
expressing cells (dark brown cytoplasmic staining) were detectable in the antropyloric 
mucosa of P7 Pdx1-/- mice at a similar frequency as in wild type.  (D,E) Somatostatin-
expressing cells were also detected in transgene-rescue mice at P7. 
A B
Pdx1+/+
Pdx1-/-Pdx1-/-;b3Tg
Pdx1-/-;b1Tg
C
FE
D
Pdx1+/+ Pdx1-/-;b3Tg
58
 59 
was still weaker than wild type (Fig. 3.7C).  Consistent with previous reports (Fujitani et al., 
2006; Larsson et al., 1996), expression of gastrin in the antropyloric mucosa was 
undetectable in P7 Pdx1-/- mice (Fig. 3.7H).  The number of gastrin cells appeared to be 
slightly fewer than wild type in Pdx1-/-;b1Tg and was substantially reduced in Pdx1-/-;b3Tg at P7 
(Fig. 3.7E-G).  The number of somatostatin cells in the stomach was not reduced in Pdx1-/- or 
in transgene-rescue mice (Fig. 3.8C-F).  
 
Well-differentiated duodenum in Pdx1-/-;Tg mice 
To assess the phenotypic consequences of reduced Pdx1 expression in the duodenum, 
we compared morphology and marker expression in wild-type, Pdx1+/-, Pdx1-/- and Pdx1-/-;Tg 
mice.  Pdx1+/- mice were indistinguishable from wild type for all of the criteria examined, 
and for simplicity are therefore omitted from Fig. 3.9.  While the transformation from a 
pseudostratified epithelium to the initial crypt-villus architecture occurs over a relatively 
short period towards the end of gestation, the maturation of the duodenum continues 
significantly after birth.  Over the first few weeks of life there is a thickening of the muscular 
wall of the duodenum, increased crypt depth, increased numbers of enteroendocrine cells, 
and proliferation of Brunner’s glands.  Our analysis focused on P7 mice because it was the 
latest stage at which Pdx1-/- pups could consistently be recovered.  The major anatomical 
features of the duodenum, i.e., the crypts, villi and submucosal Brunner’s glands, were all 
present in Pdx1-/- pups, but the villi tended to be much shorter and sparser than wild type, 
with a crumpled appearance (Fig. 3.9B,D).  Brunner’s glands were greatly reduced in number 
and were poorly differentiated based on morphology and PAS staining (Fig. 3.9H).  These 
defects were not found in Pdx1-/-;Tg mice (Fig. 3.9C,F,I) representing either the b1 or b3 lines. 
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Fig. 3.9  Well-differentiated duodenal epithelium in Pdx1-/-;Tg mice at P7.  (A – C)
Apical villin expression (red), characteristic of differentiated enterocytes in wild-type,
Pdx1-/- and Pdx1-/-;Tg mice (green: nuclei detected with YoPro-1).  (D – F) PAS-
stained goblet cells (magenta; hematoxylin counterstain) were present at similar
frequencies in wild-type, Pdx1-/- and Pdx1-/-;Tg mice.  Villi in Pdx1-/- had a ragged
appearance not observed in Pdx1-/-;Tg.  (G – I) Number, elaboration and mucin content
of Brunner’s glands was greatly reduced in Pdx1-/-, but normal in Pdx1-/-;Tg.  Staining
as in (D – F).  (J – L) Immunoperoxidase-DAB staining of Chromogranins (brown;
hematoxylin counterstain) indicated enteroendocrine cells (arrows) in wild type, Pdx1-
/- and Pdx1-/-;Tg duodena, although fewer in Pdx1-/-.  Scale bars are 100 µm.
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The predominant duodenal epithelial cell is the enterocyte, which was confirmed to 
be present in wild-type and mutant animals by its apical villin (Fig. 3.9A-C).  The villus 
epithelium also contains mucous-secreting goblet cells, stained by the PAS method (Fig. 
3.9D-F), and hormone-producing enteroendocrine cells, identified by production of 
chromogranins (Fig. 3.9J-L).  While the frequency of goblet cells appeared unchanged in the 
Pdx1-/- mutants, the number of epithelial cells expressing chromogranins appeared lower, 
consistent with previous reports of reduced enteroendocrine cell populations in these mutants 
(Jepeal et al., 2005; Larsson et al., 1996; Offield et al., 1996).  The number of chromogranin-
expressing cells was equivalent between Pdx1-/-;Tg and wild-type pups.  Because the presence 
of specific enteroendocrine hormone-producing cells is differentially sensitive to the loss of 
Pdx1 (Jepeal et al., 2005; Larsson et al., 1996; Offield et al., 1996), we analyzed our 
transgene-rescue mice for cells producing gastrin, GIP, and CCK.   
 
GIP cell number is exquisitely sensitive to the level of Pdx1 
 The number of GIP cells in the rostral duodenum is profoundly reduced in Pdx1-/- 
mice (Jepeal et al., 2005), and deletion of Area I-II-III revealed that low levels of Pdx1 
during embryogenesis resulted in dose-dependent reduction in the number of GIP cells at 
E18.5 (Fujitani et al., 2006).  In contrast to mice with Area I-II-III deletion, the duodenum of 
transgene-rescue mice showed normal levels of Pdx1 during embryogenesis, but markedly 
reduced postnatal expression.  We quantified the number of GIP-expressing cells to evaluate 
whether postnatal maintenance of the GIP cell population required sustained expression of 
Pdx1.  Gastrin- and CCK-producing cells were included in the quantitative analysis because 
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they have been shown to be decreased in Pdx1-/- mice (Larsson et al., 1996; Offield et al., 
1996).   
Compared to wild type, the frequency of GIP cells was reduced by approximately 
50% in Pdx1-/-;b1Tg, and 90% in Pdx1-/-;b3Tg mice (Fig. 3.10A).  No GIP-expressing cells were 
identified in extensive sampling of rostral duodena from three Pdx1-/- mice.  A slight, but 
statistically insignificant, reduction in GIP cell frequency was found in Pdx1+/- mice 
compared to wild type.  The trend of GIP cell frequency among the five genotypes correlated 
well with the intensity of Pdx1 immunostaining on duodenal sections processed side-by-side 
under identical conditions (Fig. 3.5G,J,M,N), suggesting that Pdx1 has a dose-dependent 
influence on the postnatal generation of GIP-producing cells.  The frequencies of gastrin- and 
CCK-expressing cells were reduced in Pdx1-/- mice by approximately 57% and 60% 
respectively, but were not significantly affected in mice of the other genotypes (Fig. 
3.10B,C).  The 25% reduction in CCK cell frequency observed in Pdx1-/-;b3Tg mice compared 
to wild type had a P value between 0.1 and 0.05 by t-test analysis, suggesting that the 
reduction was correlated with the transgene-rescue genotype.  In summary, duodenal GIP, 
gastrin and CCK cells were reduced in Pdx1-/- mice at P7, but a strong dose-dependent effect 
of Pdx1 was found for GIP only.  We also observed a dose-dependent influence of Pdx1 on 
antropyloric gastrin cells (Fig. 3.7).  The specific effect of postnatal Pdx1 dosage on 
duodenal GIP and antropyloric gastrin cells is consistent with our previous analysis of Pdx1 
dosage effects (Fujitani et al., 2006). 
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Fig. 3.10  Frequency of enteroendocrine cells in duodenum at P7.  The number of GIP, 
gastrin and CCK cells relative to the total number of duodenal epithelial cell nuclei was 
determined in longitudinal sections of duodenum from wild-type (n=5), Pdx1+/- (n=5), Pdx1-/-
;b1Tg (n=4), Pdx1-/-;b3Tg (n=4) and Pdx1-/- (n=3) mice (see Methods for details).  Crosses 
indicate values for individual mice, bars the mean of each group.  (A) The frequency of GIP 
cells varied by genotype in accordance with the relative level of Pdx1 expression observed 
(Fig. 3.5).  P < 0.05 for Pdx1-/-;b1Tg, Pdx1-/-;b3Tg and Pdx1-/- compared to wild type.  (B) 
Gastrin cell frequency in the duodenum was reduced to varying degrees in Pdx1-/- mice but 
was similar among mice of the other genotypes examined.  P < 0.05 for Pdx1-/- compared to 
wild type.  (C) CCK cell frequency was significantly reduced only in Pdx1-/- (P < 0.05) but 
appeared to follow a slight downward trend paralleling the relative levels of Pdx1 shown in 
Fig. 3.5.  
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Temporal and spatial correlation of Pdx1 and enteroendocrine hormone expression 
To determine if the reduction in duodenal GIP and stomach gastrin cells was 
temporally synchronized to the postnatal reduction in Pdx1 expression in the transgene-
rescue mice, GIP and gastrin expression were examined at E16.5 and P0 (Fig. 3.11).  At 
E16.5, gastrin expression was detected in both stomach and duodenum in wild-type, Pdx1-/-
;b1Tg and Pdx1-/-;b3Tg mice.  The same distribution was observed at P0 for wild-type and b3Tg 
mice.  In Pdx1-/- mice, gastrin was detected in the duodenum but not stomach at E16.5 or P0.  
These results indicate that antropyloric gastrin cells form normally in Pdx1-/-;Tg mice during 
late embryogenesis, when Pdx1 is still robustly expressed in the posterior foregut, but the 
number of gastrin cells decreases during the first week of life, subsequent to the reduction of 
Pdx1 expression.  GIP-expressing cells were not detected in the rostral duodena of any of the 
various genotypes at E16.5, and were only found in wild type at P0 (note: b1Tg rescue mice 
were not evaluated at P0).  These data suggest that the initial formation of GIP cells was 
impaired in Pdx1-/-;b3Tg mice, because the time of appearance of GIP-expressing cells in wild-
type mice is similar to the stage when transgene-rescue mice exhibit decreased duodenal 
Pdx1 expression.  
Previous studies showed that Pdx1 is expressed throughout the rostral duodenal 
epithelium, declining caudally to a punctate expression pattern (Offield et al., 1996).  These 
sparse caudal cells have been postulated to be enteroendocrine cells, but to our knowledge 
this has not yet been directly tested.  Considering the evidence from the current and previous 
studies for strong dependence of GIP cells on Pdx1, we tested for co-expression of Pdx1 and  
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Fig. 3.11  Development of gastrin and GIP cells in Pdx1 mutants.  (A) DAB-labeling of 
gastrin-expressing cells in the stomach and duodenum of E16.5 embryos.  Gastrin-positive 
cells could be found in both stomach and duodenum of wild-type, Pdx1-/-;b1Tg and Pdx1-/-;b3Tg 
embryos.  In Pdx1-/- embryos, gastrin was detectable in the duodenum but not in the stomach.  
Although there are more gastrin-producing cells in the Pdx1-/-;b1Tg section than in the wild-
type section, this was not consistently observed.  (B) Gastrin-expressing cells were present in 
stomach and duodenum of newborn wild-type and Pdx1-/-;b3Tg pups.  Gastrin cells were not 
found in the stomach of Pdx1-/- newborns, but were present in the duodenum (arrows) in 
reduced numbers as compared to wild type.  (C) GIP expressing cells were detected in the 
rostral duodenum of newborn wild-type mice but not in Pdx1-/-;b3Tg or Pdx1-/- mice.  For all 
images in this figure, the compound microscope iris was narrowed to aid visualization of 
unstained tissues. 
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Fig. 3.12  Comparison of Pdx1 expression and enteroendocrine cell distribution
in mature duodenum.  Immunofluorescence analysis for (A – C) Pdx1 (green) and
GIP (red), or (D,E) Pdx1 (green) and Chromogranins (red).  (A) In rostral wild-type
duodenum, all epithelial cells robustly expressed Pdx1.  (B) In the caudal portion of
wild-type duodenum, Pdx1 expression was weaker with isolated strongly
immunopositive epithelial cells.  All of the GIP-expressing cells observed in the
caudal region had relatively strong Pdx1 expression.  Background in the red channel
(including RBC autofluorescence in the stromal tissue) is rather high in this panel
because the gain was increased to detect weak GIP labeling.  (D) Some
Chromogranin-expressing cells in caudal wild-type duodenum strongly expressed
Pdx1 (yellow arrow), but many did not.  Some Pdx1 high-expressers did not co-label
for Chromogranins (blue arrow).  (C,E)  The variegated pattern of Pdx1 expression in
mature Pdx1-/-;b3Tg duodenum did not appear to influence the distribution of GIP cells
(C) or of enteroendocrine cells in general (E). Pancreatic islet at lower edge of panel E
is intensely Pdx1- and Chromogranin-positive.  All sections from 8-month-old mice.
Yellow arrows, double-labeled cells.  Purple arrows indicate enteroendocrine cells
with low/undetectable Pdx1 expression.  Scale bars are 100 µm.
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GIP in the caudal duodenum.  All caudal GIP-producing cells had strong Pdx1 
immunoreactivity (e.g., Fig. 3.12B), while co-labeling for Pdx1 and the general endocrine 
marker chromogranin A/B revealed that the majority of endocrine cells in the caudal 
duodenum expressed relatively low levels of Pdx1 (Fig. 3.12D).  These results are consistent 
with greater dependence of GIP expression on Pdx1 as compared to other duodenal 
enteroendocrine hormones.  Because the duodenal epithelium of Pdx1-/-;Tg mutants showed a 
low level of Pdx1 expression with considerable regional variability (e.g., Fig. 3.12C), we 
hypothesized that the remaining GIP cells in these mice would be found in regions with 
relatively high Pdx1 expression.  In contrast, however, GIP-producing cells with little or no 
Pdx1 immunoreactivity were often observed in Pdx1-/-;b3Tg mice, and adjacent Pdx1 high- and 
low-expressing regions showed no noticeable difference in the frequency of GIP-expressing 
cells (Fig. 3.12C).  Chromogranin-positive cells also appeared equally abundant regardless of 
the level of Pdx1 expression (Fig. 3.12E).  We conclude that while wild-type GIP cells 
express a relatively high level of Pdx1, and wild-type levels of Pdx1 are required to produce 
the normal number of GIP cells, GIP hormone can still be produced by cells expressing a low 
level of Pdx1.  
 
Discussion 
 
Proximal sequences sufficient for pancreatic Pdx1 expression 
The studies described above indicate that cis-acting elements within 12.5 kb 
surrounding and including the Pdx1 coding sequence are sufficient to regulate most aspects 
of Pdx1 gene expression in the pancreas.  Expression of Pdx1 from the 12.5 kb transgene 
recapitulated the normal spatiotemporal expression profile of Pdx1 and supported full 
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pancreatic morphogenesis, specification of all endocrine islet cells in properly organized 
islets, and glucose-stimulated insulin secretion from mature β cells.  One possibility to 
explain the increased expression of Pdx1 in most pancreatic acinar cells and some α and PP 
cells is that the transgene lacks regulatory elements that suppress expression of Pdx1 in non-
β cells in the mature pancreas. 
The only non-coding regions in the transgene with at least 100 bp of greater than 75% 
conservation between mice and humans are the previously identified Areas I, II and III, 
which reside within the 4.6 kb of 5′ non-coding sequence (Fig. 3.1A).  The sufficiency of this 
region to regulate most aspects of Pdx1 expression is consistent with lacZ-reporter 
expression profiling experiments (Gannon et al., 2001; Stoffers et al., 1999), which showed 
that the proximal 4.6 kb sequence (from the XbaI site at -4.5 kb to the translational start 
codon) mediated expression throughout the endogenous Pdx1 expression domain.  The 
pancreatic buds of our transgene-rescue mice were indistinguishable from wild type at E12.5, 
suggesting that the 4.6 kb promoter region is sufficient to initiate expression in the full 
pancreatic progenitor population from early stages of pancreas development.  Although the 
rescue transgene was sufficient to mediate the proper spatiotemporal expression of Pdx1 in 
embryonic gut epithelium, it did not support robust expression of Pdx1 in the postnatal 
stomach and duodenum. 
 
Complementation phenotype consistent with enhancer deletion results 
 Our recent findings (Fujitani et al., 2006) demonstrated that mice homozygous for a 
targeted deletion of the Area I-II-III enhancer region had severely impaired pancreas 
development, but only mild defects in the duodenum and stomach.  The current findings are 
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largely consistent with those results, showing that complementation rescue of Pdx1-/- with a 
transgene covering Area I-II-III is sufficient to support pancreas development but only 
weakly promotes Pdx1 expression in postnatal duodenum and stomach.  One caveat to the 
enhancer deletion study was that deletion of an enhancer region from the Pdx1 locus might 
affect expression of neighboring genes, such as Gsh1 and Cdx2 in the evolutionarily 
conserved Parahox gene cluster (Brooke et al., 1998).  By evaluating expression of Pdx1 
from randomly integrated transgenes, we confirmed that regulation of Pdx1 by proximal 
elements is sufficient for pancreas morphogenesis, independent of other gene regulatory 
events that may occur in the endogenous locus.  Because both lines that expressed detectable 
Pdx1 showed identical spatiotemporal expression, it seems reasonable to conclude that the 
expression pattern was specific to the regulatory elements contained in the transgene 
sequence, and was not significantly influenced by the site of transgene integration. 
 
Transgene rescues glucose tolerance fully in Pdx1+/-, partially in Pdx1-/- 
Both transgenic lines were able to rescue the glucose intolerance that results from 
heterozygosity at the endogenous Pdx1 locus, and complementation of Pdx1-/- mice resulted 
in glucose clearance that was intermediate between wild type and Pdx1+/-.  We were 
surprised to discover that the Pdx1-/-;b1Tg mice were glucose intolerant despite producing 
higher levels of Pdx1 than wild type.  We have not yet been able to determine the cause of 
glucose intolerance in these mice, but one possibility is that the transgene-rescue mice have a 
subtle defect in islet development that results in a mildly abnormal glucose response even 
when their β cells contain abundant Pdx1.  Gap junction connectivity between β cells and 
interactions between β cells and the islet capillary network are important for islet function 
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(Rocheleau et al., 2006; Lammert et al., 2003).  Subtle abnormalities in the expression of 
Pdx1 in developing or maturing islets might disrupt the proper establishment of these 
interactions, resulting in impaired glucose tolerance.  Another possibility is that the impaired 
islet function is secondary to the reduced number of GIP cells in the transgene-rescue mice.  
GIP has a well-characterized incretin effect enhancing the response of β cells to glucose 
(reviewed by Drucker, 2006), such that decreased GIP production in the transgene-rescue 
mice may limit the responsiveness of their β cells.   
Mice that had both wild-type alleles of Pdx1 plus either b1Tg or b3Tg (Pdx1+/+;Tg) 
produced supraphysiological levels of pancreatic Pdx1.  Neither of these genotypes had 
deleterious effects on pancreatic development or function, nor was there accelerated glucose 
clearance in the presence of excess Pdx1.  We conclude that the wild-type level of Pdx1 is 
required for normal glucose clearance, but that excess Pdx1 does not enhance the response of 
β cells to glucose challenge. 
 
Proximal Pdx1 promoter elements express poorly in duodenum 
 Although both transgenic alleles produced more Pdx1 in the pancreas than a single 
wild-type allele (i.e., Pdx1+/-), rescue of Pdx1-/- with either transgenic allele resulted in much 
weaker expression of Pdx1 in the duodenum than was observed for Pdx1+/- mice (cf. Fig. 
3.5J,M,N).  The transgene-rescue mice also had reduced Pdx1 expression in the stomach, but 
the reduction compared to the wild-type level was not as dramatic as in the duodenum.  
Stoffers et al. (1999) examined expression of a lacZ reporter driven by the 4.6 kb 5′ Pdx1 
promoter region and reported weak X-gal staining in the duodenal epithelium, even though 
Pdx1 protein was readily detected by immunohistochemistry.  They speculated that weak X-
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gal staining in the duodenum resulted from poor perdurance of β-galactosidase after 
production in the crypts.  Arguing against this reasoning, however, mice heterozygous for a 
knock-in of lacZ into the Pdx1 locus are X-gal positive throughout the epithelium of the 
rostral duodenum (Offield et al., 1996).  The difference in duodenal expression between the 
knock-in and transgenic β-galactosidase reporter alleles is consistent with the reduced level 
of Pdx1 expressed from our 12.5 kb rescue transgene as compared to the endogenous locus.  
These results suggest that sequences upstream of -4.5 kb are required for full duodenal 
expression.   
 
Dose-dependent influence of Pdx1 on GIP and antral stomach gastrin cells 
The intensity of Pdx1 immunoreactivity indicated that b1Tg produced more Pdx1 
protein in the duodenum than b3Tg, but less than Pdx1+/-.  We were therefore able to analyze 
the influence of a spectrum of Pdx1 protein levels in the duodenum: Pdx1+/+ > Pdx1+/- > 
Pdx1-/-;b1Tg > Pdx1-/-;b3Tg > Pdx1-/-.  Interestingly, the frequency of GIP-expressing cells at one 
week of age followed the same trend as the level of Pdx1 protein.  GIP has recently been 
shown to be a direct transcriptional target of Pdx1, and expression of GIP is virtually absent 
from Pdx1-/- duodenal epithelium (Jepeal et al., 2005).  If Pdx1 was simply a direct 
transactivator of the GIP gene, then reduced Pdx1 might have resulted in the same number of 
GIP-expressing cells, but each expressing less GIP.  We observed, however, a 90% reduction 
in the proportion of duodenal epithelial cells that expressed GIP in the Pdx1-/-;b3Tg mice, 
suggesting that Pdx1 affects the frequency at which enteroendocrine progenitors become 
allocated to the GIP cell fate.  In contrast, the proportion of duodenal epithelial cells 
producing gastrin and CCK in the transgene-rescue mice was not significantly reduced 
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compared to wild type, although the number of these cell types is substantially reduced in 
Pdx1-/- mutants.  This suggests that a relatively small amount of Pdx1 is sufficient for 
formation of CCK and duodenal gastrin cells. 
The number of gastrin cells in the stomach appeared to be greatly reduced in Pdx1-/-
;b3Tg mice despite a lack of significant change in duodenal gastrin cell frequency.  While 
some gastrin cells were present in the duodena of Pdx1-/- mice, stomach gastrin cells were 
undetectable at E16.5, P0 and P7 in Pdx1-/- mice.  The stricter dependence of antropyloric 
gastrin cells on Pdx1 may reflect region-specific differences in the progenitor cell 
populations in the stomach and duodenum.  
 
Potential in vivo roles of Area IV 
 Among the previously characterized evolutionarily conserved regions of Pdx1, Area 
IV is the only one not contained in our transgene, making it an obvious candidate for the cis-
regulatory activity required for full expression of Pdx1 in the duodenum and stomach.  
However, the factors that likely bind within Area IV also bind within Areas I, II and III, and 
are primarily expressed in endocrine pancreas (Fig. 3.13).  Furthermore, in vitro analysis of 
Area IV activity suggested that it functions in synergy with Areas I and II to promote β-cell-
specific transcription (Gerrish et al., 2004).  The current findings raise the possibility that 
Area IV may contain additional binding sites for factors that are particularly important for 
transcription in foregut crypt stem cells.  Although the transgene provided near-to or greater-
than wild-type levels of Pdx1 protein in the pancreas, these data do not rule out an in vivo 
role for Area IV in enhancing pancreatic Pdx1 expression, or that the activity of Area IV may  
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Fig. 3.13  Overview of transactivator interactions on Pdx1 5′ non-coding region.  Top, 
previously reported sites of protein-DNA interaction in relation to regions of phylogenetic 
sequence conservation (Ben-Shushan et al., 2001; Gerrish et al., 2001; Gerrish et al., 2000; 
Gerrish et al., 2004; Jacquemin et al., 2003; Marshak et al., 2000; Samaras et al., 2002; 
Samaras et al., 2003; Sharma et al., 1997; Van Velkinburgh et al., 2005; Wu et al., 1997).  
“?”, hypothetical transactivator promoting expression in postnatal foregut.  Middle, text 
boxes indicate tissues where proximal or distal cis-regulatory regions seem to be of particular 
importance for Pdx1 expression.  “β cells” in bold or grey for the proximal or distal region, 
respectively, indicate the stronger influence of proximal regions on β-cell-specific 
expression, from in vitro and in vivo evidence.  Bottom, embryonic and adult locations of 
Pdx1 expression and its transactivators that are reported as expressed in those tissues 
(Coffinier et al., 1999; Maestro et al., 2003; Matsuoka et al., 2004; Naya et al., 1997; Rausa 
et al., 1997; Sander et al., 1997; St-Onge et al., 1997; Sussel et al., 1998). 
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be required under specific physiological demands.  For instance, the presence of tandem 
copies of the transgene in the b1 and b3 lines may circumvent the requirement for synergy 
between Area IV and Areas I and II.  Another possibility is that Area IV may contribute to 
regulation of Pdx1 during islet development, and the absence of that regulatory influence in 
the Pdx1-/-;Tg mice might explain the impairment of glucose tolerance despite abundant Pdx1 
in mature Pdx1-/-;b1Tg pancreas.  In support of this potential role of Area IV, previous analysis 
of rescue of Pdx1-/- using a transgene that included Area IV (Gannon et al., 2001) showed 
GTT performance that appears to be closer to wild type than the current results using the 12.5 
kb transgene.  We were unable to directly compare the 14.5 kb and 12.5 kb transgenes 
because the 14.5 kb transgenic lines were not kept, and in any case we would be unable to 
rule out position of transgene integration effects.  We plan to delete distal enhancer elements 
from the endogenous Pdx1 locus, which will hopefully resolve these uncertainties. 
Our recent examination of mouse and human Pdx1/IPF1 genomic sequence 
alignment using the Lawrence Berkeley Laboratories online Vista browser 
(http://pipeline.lbl.gov) revealed two additional regions of greater than 75% sequence 
conservation within 5 kb upstream of Area IV and additional conserved regions between 
Pdx1 and its nearest 5′ located neighbor, the transcriptional regulator-encoding gene, Gsh1.  
These as-yet uncharacterized conserved sequences may also contribute to cis-activation of 
Pdx1 in the duodenum and stomach.   
 
Shared and distinct roles of proximal and distal promoter elements 
 Cis-regulatory sequences included in the 12.5 kb transgene were sufficient for 
expression in embryonic duodenal and stomach endoderm but not in the mature organs.  
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Deletion of Area I-II-III, the only highly conserved non-coding sequence present in the 12.5 
kb transgene, mildly reduced expression in both embryonic and mature gut tissues (Fujitani 
et al., 2006).  These results suggest that proximal and distal promoter elements cooperatively 
promote expression of Pdx1 in the posterior foregut.  In the embryonic duodenum and 
stomach, lack of either proximal or distal cis-regulatory elements can be compensated by the 
remaining regulatory regions.  In the postnatal gut, however, distal regulatory regions appear 
to be more important than proximal elements for maintenance of Pdx1 expression.  Review 
of previously characterized transactivator-binding motifs in the 5′ Pdx1 locus (Fig. 3.13) 
reveals several binding sites for the Foxa and Hnf factors, which are broadly expressed in 
early endoderm, in both the proximal and distal promoter regions.  The presence of multiple 
binding sites for these factors may explain the maintenance of at least basal levels of Pdx1 
expression throughout the embryonic posterior foregut when either proximal or distal 5′ 
sequences are removed.   
Several binding sites for factors enriched in pancreatic endocrine cells are found 
within Areas I and II, which may account for the strong pancreatic phenotype of Area I-II-III 
deletion mutants (Fujitani et al., 2006).  Pax6 and MafA binding in Area II may be 
particularly important for expression of Pdx1 in β cells (Samaras et al., 2002; Samaras et al., 
2003).  Based on the results of the current study, it seems likely that there is a cis-regulatory 
activity in the distal 5′ region that is important for Pdx1 transcription in duodenal crypt stem 
cells, an activity that cannot readily be accounted for by previously characterized 
transactivator binding interactions.   
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CHAPTER IV 
 
TISSUE-SPECIFIC RECOMBINATION OF PDX1 FLOXED ALLELES 
 
Introduction 
Onset of Pdx1 expression at E8.0-8.5 is specific to endoderm that will give rise to the 
pancreatic buds (Gu et al., 2002).  Pdx1 is expressed homogeneously in the early pancreatic 
buds and the level of expression subsequently becomes upregulated in differentiating and 
mature β cells and downregulated in other differentiated pancreatic tissues (Guz et al., 1995).  
A recent report showed that upregulation of Pdx1 in differentiating β cells occurs after the 
initiation of insulin and Nkx6.1 expression but prior to the switch from MafB to MafA 
expression (Nishimura et al., 2006), indicating that upregulation of Pdx1 is associated with 
maturation of specified β cells.   
Targeted inactivation of Pdx1 resulted in arrest of pancreatic outgrowth and 
differentiation soon after the initial evagination of the pancreatic buds, resulting in the 
replacement of the pancreas by a duct-like rudiment that lacked mature pancreatic tissue 
except for a few glucagon-expressing cells (Jonsson et al., 1994; Offield et al., 1996).  Two 
approaches have been employed to circumvent the early arrest of pancreas development in 
Pdx1-/- mice and study later roles of Pdx1 in pancreatic tissue.  One approach was to 
inactivate the Pdx1 gene specifically in β cells.  These experiments revealed that Pdx1 is 
required for expansion (Gannon et al., in preparation) and maintenance of the β cell 
population (Ahlgren et al., 1998).  Conditional deletion of Pdx1 in postnatal β cells resulted 
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first in loss of Glut2 expression, followed by loss of insulin expression and eventually a 
decrease in the number of β cells (Ahlgren et al., 1998).   
The other approach that has been used to study the requirement for Pdx1 beyond the 
early stages of pancreas development was to make expression of Pdx1 repressible by 
treatment with doxycycline (Dox).  In adult mice, β cells lost expression of insulin after onset 
of Dox treatment, but insulin expression was restored after removal of Dox (Holland et al., 
2002, 2005).  Expression of the acinar cell markers amylase and elastase was also 
downregulated after repression of Pdx1 expression (Holland et al., 2002).  It remains unclear 
if prolonged suppression of Pdx1 would result in failure to maintain the viability of endocrine 
or exocrine tissue, or if the small amount of Pdx1 that is still expressed in the presence of 
Dox is sufficient for maintenance of pancreatic endocrine and exocrine mass.  When Pdx1 
was repressed by Dox during embryogenesis, proliferation and maturation of endocrine and 
exocrine pancreatic cells were arrested shortly after Dox addition, but the arrested cells 
survived until the experiment was terminated at birth (Hale et al., 2005).  It is unclear 
whether the developmental arrest results primarily because precursor cells fail to differentiate 
or because differentiated cells fail to proliferate. 
Targeted deletion of a conserved enhancer region (Area I-II-III) of Pdx1 that 
promotes β-cell-specific gene expression resulted in a hypomorphic allele that impaired 
initial pancreatic outgrowth and severely impaired β cell development (Fujitani et al., 2006).  
The amount of acinar tissue formed in the mutants was substantially less than in wild-type 
mice, perhaps due to the early bud outgrowth defect.  The acinar tissue that formed appeared 
to be well-differentiated but expressed less Pdx1.  These data indicated that early stages of 
pancreas development and generation of β cells from endocrine precursors require a high 
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level of Pdx1 expression that is dependent on the Area I-II-III enhancer, but that a lower 
level of Pdx1 may be sufficient for acinar-cell specification and maturation.  The four major 
pancreatic endocrine cell types arise from common Ngn3-expressing progenitors (Gu et al., 
2002).  Because production of β cells was more severely affected than the other endocrine 
cell types in mice homozygous for the enhancer deletion, one interpretation could be that the 
level of Pdx1 expression influences the cell-fate choice of endocrine progenitors. 
Mice that were heterozygous for deletion of Area I-II-III had worse defects than 
Pdx1+/- mice in terms of glucose intolerance, decreased Glut2 expression, and disrupted islet 
architecture (including infiltration of peripheral cell types into the core and a significant 
increase in PP cells).  Because other experiments suggested that the Pdx1ΔI-II-III allele had 
intermediate activity between a wild-type and null allele, it was surprising that Pdx1+/ΔI-II-III 
mice had a stronger islet phenotype than Pdx1+/- mice.  One explanation could be that lack of 
the enhancer, even when absent on one of two alleles, interferes with the upregulation of 
Pdx1 during β-cell maturation, which may impair β-cell differentiation and result in 
improper patterning of the islets. 
To test whether the dominant negative influence of lack of the Area I-II-III enhancer 
on islet function results from a role for the enhancer during islet development or a role of the 
enhancer in mature β cells, we used the Cre/loxP system to delete the Area I-II-III enhancer 
in pancreatic endocrine progenitors and in differentiated β cells.  A conditional null allele of 
Pdx1 was tested side-by-side with the floxed Area I-II-III allele to compare the effects of 
varying levels of Pdx1 reduction at different stages of endocrine development.  Specifically, 
we wanted to test if removing Pdx1 would prevent specification of endocrine progenitors to 
the β-cell lineage, and if this effect would be manifest as arrested development of immature β 
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cells or conversion of β-cell precursors to other differentiated cell fates.  In addition, we used 
a pancreatic acinar cell specific Cre transgene to recombine the conditional Area I-II-III and 
conditional null alleles of Pdx1 to determine if differentiated acinar cells require Pdx1, and if 
so whether a low level of Pdx1 would suffice for acinar cell maturation and maintenance. 
 
Results 
These studies employed two Cre-sensitive alleles of Pdx1 generated previously in our 
laboratory (Fig. 4.1).  In one allele, the second exon of Pdx1 is flanked by loxP sites resulting 
in a null allele after Cre-mediated recombination (floxE2; M. Gannon, manuscript in 
preparation).  The other allele contains loxP sites flanking the 1.2 kb region encompassing 
the phylogenetically conserved enhancer regions known as Areas I, II and III (flox123; 
Fujitani et al., 2006).  Mice were bred to generate offspring of the genotype 
Pdx1floxE2/flox123;ROSA26R/R, where ROSA26R is a reporter allele that expresses the lacZ gene 
after it is recombined by Cre (Soriano, 1999).  Crosses between Pdx1floxE2/flox123 mice and 
Cre-expressing mice resulted in offspring with conditional recombination of either floxed 
allele.  This strategy allowed us to control for potential genetic background effects by 
comparing conditional null versus conditional hypomorphic phenotypes among littermates.  
Lineage-specific activity of Cre was confirmed based on the pattern of expression of the 
ROSA26R reporter allele. 
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Fig. 4.1  Gene targeting strategies for generation of floxed Pdx1 alleles.   
(A) Targeting construct used to generate the Pdx1floxE2 allele.  The PGK-neoR/HSV-TK 
selection cassette was removed prior to using this strain for conditional deletion experiments.  
Recombination of the remaining two loxP sites deletes Exon 2, resulting in a null allele.  
Detailed characterization of this allele will be reported in an upcoming publication from 
Maureen Gannon, VUMC Department of Medicine.  (B) Strategy for generating the 
Pdx1flox123 allele.  Detailed description of the targeting construct can be found in Fujitani et 
al., 2006. 
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Mice expressing Cre transgenes were bred to heterozygosity for a null allele of Pdx1 
(Pdx1XBko; Offield et al., 1996).  We reasoned that offspring with one floxed allele of Pdx1 
and one null allele would be convenient for detecting conditional-deletion phenotypes 
because only one allele of Pdx1 would need to be recombined, hopefully providing greater 
sensitivity to transient or low-level activity of Cre.  In addition, because Pdx1+/- mice have 
impaired pancreatic islet function (Dutta et al., 1998; Ahlgren et al.,1998; Brissova et al., 
2002; Johnson et al., 2003) and develop worsening islet disorganization with age (Johnson et 
al., 2003), we thought it likely that Pdx1flox/- mice would be sensitized to further reduction in 
Pdx1 expression even if the efficiency of Cre-mediated recombination was fairly low.  
 
Ngn3Cre-mediated deletion 
 To examine the role of Pdx1 in pancreatic endocrine progenitors, we used a transgene 
expressing Cre recombinase from Ngn3 regulatory sequences (Gu et al., 2002) to recombine 
the floxE2 and flox123 alleles.  Ngn3 is transiently expressed in the precursors of all 
pancreatic endocrine cells, and Ngn3Cre mediates recombination in a high percentage of 
endocrine cells of the four major pancreatic endocrine lineages (Gu et al., 2002).  Previous 
characterization of the Ngn3Cre mice by Gu et al. utilized the Z/AP transgenic reporter for 
Cre activity and showed that recombination in the pancreas was limited to islets.  When we 
crossed the Ngn3Cre mice to ROSA26R/R mice we found that virtually all islet tissue was 
lineage-labeled, but there was also significant recombination in non-endocrine tissue of the 
pancreas and duodenum (Fig. 4.2A,C,E).   
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Fig. 4.2  Pattern of recombination mediated by Ngn3Cre transgenes.  Recombination of 
the ROSA26R reporter was evaluated by XGal staining of posterior foregut tissues in mice 
expressing the Ngn3Cre (A, C, E) and Ngn3CreBAC (B, D, F) transgenes.  The Ngn3Cre 
transgene consistently activated the reporter in pancreatic endocrine tissue (dashed outlines 
in C), but also recombined the reporter in most smooth muscle (A, E) and duodenal crypts 
(E), as well as substantial patches of pancreatic exocrine tissue (C).  (B) Reporter activation 
in Ngn3CreBAC transgenic mice was consistently restricted to the pancreas, as well as gut 
enteroendocrine cells (faintly visible in duodenal whole-mount).  (D) In most 
Ngn3CreBAC;ROSA26R pancreata, the majority of endocrine islets were labeled (dashed 
outlines) and scattered acinar clusters were also recombined (arrow).  (F) In a few 
Ngn3CreBAC;ROSA26R animals extensive recombination was seen in pancreatic acinar 
tissue.  Arrow in (F) indicates an acinar lobule where all of the cells are labeled by XGal.  
Sections in (C-F) were counterstained with hematoxylin. 
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Genetic background may have contributed to the discrepancy between our results and 
the previous report.  The transgene was on a mostly ICR background when we received the 
mice, but we subsequently bred them onto a C57BL/6:DBA/2J (B6D2) hybrid background 
for at least three generations before using them in these experiments.  Also, we have heard 
anecdotal evidence that the ROSA26 reporter is more sensitive to Cre activity than the Z/AP 
reporter, perhaps because the distance between the loxP sites is significantly greater in the 
Z/AP reporter (~4.5kb compared to ~2.3kb).  Thus, there may be low-level activity of the 
Ngn3Cre transgene in early progenitors that is sufficient to recombine ROSA26R but not 
enough to recombine Z/AP.   
Regardless, the Ngn3Cre transgene is adequte for our study because it mediates Cre 
activity in all endocrine progenitors, so we were able to evaluate the role of Pdx1 in 
endocrine differentiation independent of the general requirement for Pdx1 for growth and 
maturation of the pancreas.  In addition, we recently obtained the Ngn3CreBAC transgenic 
mice reported by Schonhoff et al. (2004b).  These mice provided more precisely restricted 
recombination in endocrine progenitors (Fig. 4.2B,D), although some mice showed 
substantial ROSA26R activation in pancreatic acinar tissue (Fig. 4.2F).  We have begun to use 
the Ngn3CreBAC transgene to corroborate and extend our findings from Ngn3Cre-mediated 
deletion of the floxed Pdx1 alleles, as described below. 
 Ngn3Cre;Pdx1floxE2/-;ROSA26R/+ mice were examined at one week of age (P7).  The 
amount of pancreatic tissue in the conditional mutants was substantially reduced compared to 
littermates (data not shown), likely resulting from deletion of Pdx1 in some of the early 
pancreatic progenitors, consistent with the pattern of recombination shown in Fig. 4.2.  
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Acinar and ductal structures appeared to be properly organized within the reduced mass of 
pancreatic tissue and the number of islets seemed consistent with the reduction in total organ 
size, though the individual islets were significantly smaller than in littermates (e.g. Fig. 4.4).   
Co-labeling with XGal and IHC for Pdx1 or insulin indicated that Cre had been 
activated in progenitors of all of the islet cells (Fig. 4.3).  Pdx1 expression was retained in a 
minority of the islet cells and insulin was expressed primarily in the Pdx1-positive cells.  
This result suggested that the floxE2 allele was less efficiently recombined than ROSA26R but 
was recombined in most endocrine progenitors.  The finding that the reduction in the number 
of insulin expressing cells paralleled the efficiency of conditional deletion of Pdx1 was 
consistent with previous reports of loss of β cells after conditional deletion of Pdx1 (Ahlgren 
et al., 1998, Gannon et al., in preparation).   
 Immunostaining for the other islet hormones, i.e. glucagon, somatostatin, and 
pancreatic polypeptide (PP), revealed a relative increase in the proportion of islet cells 
expressing these hormones (Fig. 4.4).  The increase in non-β cells may have resulted from 
crowding together of the peripheral islet cells due to a reduction in the number of β cells in 
the islet core.  However, the increase in the proportion of islet cells expressing PP appeared 
to be consistently greater than the increase in glucagon and somatostatin cells.  This 
observation led us to consider the possibility that a common precursor of β and PP cells was 
being shunted to PP cell fate after deletion of Pdx1 from endocrine progenitors. 
 The hypothesis that loss of Pdx1 resulted in shunting of common precursors to PP cell 
fate was supported by the phenotype of Ngn3Cre;Pdx1flox123/- conditional mutants.  Unlike 
the floxE2 conditional mutants, there was not an appreciable decrease in the size of the 
pancreas in P7 Ngn3Cre;Pdx1flox123/- pups (data not shown).  Islets in the flox123 conditional  
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mutants were significantly larger than in the Ngn3Cre;Pdx1floxE2/- mutants but tended to be 
slightly smaller than wild type.  Although the size and number of islets did not appear to be 
severely affected in Ngn3Cre;Pdx1flox123/- mice, the islets showed considerable mixing of the 
peripheral cell types into the core and increased numbers of PP-expressing cells (Fig. 4.4).  
The shift in the proportion of islet cells expressing insulin and PP was more obvious at P14, 
by which time the number and size of islets had grown in both wild-type and 
Ngn3Cre;Pdx1flox123/- mice (Fig. 4.5). 
 We recently examined Ngn3CreBAC;Pdx1flox123/- mice at P2 and found that they 
exhibited a similar reduction in insulin-expressing cells and increase in glucagon- and PP-
expressing cells as described above for Ngn3Cre;Pdx1floxE2/- and Ngn3Cre;Pdx1flox123/- mice 
(Fig. 4.6).  The reduction in the size of islets in Ngn3CreBAC;Pdx1flox123/- mice as compared 
to wild-type littermates was more substantial than was observed for Ngn3Cre;Pdx1flox123/-, 
and there appeared to be a greater reduction in expression of insulin and Pdx1.  These results 
suggest that Ngn3CreBAC-mediated recombination of flox123 might be more efficient than 
Ngn3Cre-mediated deletion. 
 
RIPCre-mediated deletion 
 To determine if expansion of the PP cell population was a specific result of deleting 
the floxed Pdx1 alleles from endocrine progenitors, we used a transgene expressing Cre 
under the regulation of sequences from the rat insulin promoter (RIPCre; Postic et al., 1999) 
to recombine the floxE2 and flox123 alleles in differentiating and mature β cells.  RIPCre-
mediated deletion of the flox123 allele did not appear to have an effect on the number of PP 
cells (Fig. 4.7F), but we have only examined one mouse of this genotype, so additional 
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experiments will be required for a definitive assessment of PP cell number.  We also plan to 
examine PP cell number in RIPCre;Pdx1floxE2/- mice, as the expression of this hormone was 
not described in previous reports of β-cell specific deletion of Pdx1. 
The number of β cells appeared to be decreased in the RIPCre;Pdx1flox123/- mouse and 
there was a concomitant increase in the number of glucagon-expressing cells, which were 
found distributed throughout the islets rather than restricted to the periphery as in wild-type 
mice (Fig. 4.7E).  This phenotype was similar to previous reports of RIPCre-mediated 
deletion of the floxE2 allele (Ahlgren et al., 1998; Gannon et al., in preparation), which is not 
suprising considering that germ-line deletion of Area I-II-III severely compromised β-cell 
development (Fujitani et al., 2006).   
Although decreased β cells and increased glucagon-positive cells were seen in both 
floxE2 and flox123 conditional mutants, the loss of β cells after conditional deletion of 
flox123 appeared to be less severe than was reported for the floxE2 conditional mutant.  Also, 
the RIPCre;Pdx1flox123/+ mouse had less severely impaired glucose tolerance than 
RIPCre;Pdx1floxE2/+ mice, which showed the same glucose intolerance as Pdx1+/- mice (Fig. 
4.8).  GTT analysis of more mice will be required to determine if this is a consistent 
phenotype, but based on these preliminary results, the more severe phenotype of floxE2 
deletion suggests that floxE2 is acting as a conditional null allele while flox123 acts as a 
conditional hypomorphic allele in differentiated β cells.  Indeed, Pdx1 was detectable in most 
nuclei of RIPCre;Pdx1flox123/- islets, although at lower levels than in wild-type and 
RIPCre;Pdx1flox123/+ animals (Fig. 4.7).  In contrast, Pdx1 was not detectable in most islet 
nuclei after recombination of flox123 by Ngn3Cre or Ngn3CreBAC (cf. Fig. 4.4, 4.6). 
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Fig. 4.7  No apparent alteration of PP/β cell ratio in RIPCre;Pdx1flox123/- mice.  Islets of 
4-wk-old wild-type (A, B), RIPCre;Pdx1flox123/+ (C, D) and RIPCre;Pdx1flox123/- (E, F) mice 
were stained for Pdx1 (blue), insulin (green) and glucagon (red) (left panels) or Pdx1 (blue), 
PP (green) and somatostatin (red) (right panels).  RIPCre;Pdx1flox123/- islets showed 
substantial infiltration of α cells into the islet core (E) but no apparent increase in the number 
of PP or somatostatin cells (F).  Same magnification and gain settings for all panels. 
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 If glucose tolerance of RIPCre;Pdx1flox123/+ mice is found to be consistently better 
than RIPCre;Pdx1floxE2/+ mice, it will support the hypothesis that the dominant islet 
phenotype of the Pdx1ΔI-II-III allele results from a role for Area I-II-III during an early phase 
of islet development and not from lack of the enhancer in mature β cells. We have yet to test 
glucose tolerance after Ngn3Cre-mediated deletion, but if deletion of Area I-II-III truly has 
an early dominant-negative effect then we predict that the Ngn3Cre;Pdx1flox123/+ mice will 
have worse glucose intolerance than Pdx1+/- mice. 
  
ElastaseCre-mediated deletion 
To test if Pdx1 is required cell-autonomously in acinar cells and if a lower level of 
Pdx1 expression suffices for acinar cell maintenance, we used the acinar-cell-specific 
ElastaseCre transgene (Grippo et al., 2002) to conditionally delete the floxE2 and flox123 
alleles.  Examination of P7 ElastaseCre;Pdx1flox/-;ROSA26R/+ mice revealed that 
ElastaseCre;Pdx1floxE2/-;ROSA26R/+ pancreata were much smaller than wild type, while the 
size of ElastaseCre;Pdx1flox123/-;ROSA26R/+ pancreata was only mildly decreased (Fig. 4.9).   
Histological analysis of XGal-stained ElastaseCre;Pdx1flox;ROSA26R/+ pancreata 
revealed that activity of ElastaseCre was limited to the exocrine pancreas, and that most of 
the remaining exocrine tissue in the ElastaseCre;Pdx1floxE2/-;ROSA26R/+ mice had not 
recombined ROSA26R (Fig. 4.9).  This result suggested that acinar tissue with low Cre 
activity had a selective growth advantage in ElastaseCre;Pdx1floxE2/- mice.   
The total endocrine mass appeared to be greatly reduced in the 
ElastaseCre;Pdx1floxE2/- mice and slightly reduced in the ElastaseCre;Pdx1flox123/- mice.  
Because the endocrine tissue was not lineage labeled by Cre activity, the reduction in  
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Fig. 4.9  Cell-autonomous requirement for Pdx1 in pancreatic acinar cells.  Left panels, 
whole-mount XGal staining of P7 posterior foregut tissues from mice of indicated genotypes.  
ElastaseCre-mediated deletion of Area I-II-III resulted in slightly decreased size of pancreas, 
while deletion of the conditional null allele dramatically reduced the size of pancreas.  Right 
panels, histological sections of pancreata from left panels were stained for XGal (blue/green) 
and Pdx1 (brown).  Most of the acinar tissue present in ElastaseCre;Pdx1floxE2/-;ROSA26R 
mice was not lineage-labeled, indicating selection for non-recombined cells.  Acinar tissue of 
ElastaseCre;Pdx1flox123/-;ROSA26R mice was lineage-labeled, indicating that a low level of 
Pdx1 is sufficient for development of acinar tissue to P7.   
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endocrine mass was probably secondary to reduction in the size of the pancreas resulting 
from deletion of Pdx1 in the exocrine tissue. 
  
Discussion 
 
Conditional deletion of floxed Pdx1 alleles results in supernumerary PP cells 
 Pdx1 is required for the differentiation of early pancreatic progenitors and for the 
maintenance of glucose responsiveness, insulin production, and proliferative capacity in 
differentiated β cells.  The selective impairment of β cell development in mice homozygous 
for a hypomorphic allele of Pdx1 (Pdx1ΔI-II-III/ΔI-II-III; Fujitani et al., 2006) suggested that Pdx1 
may play a role in lineage allocation of endocrine progenitors.  To investigate the influence 
of reduced Pdx1 dosage in endocrine progenitors, we used combinations of a null allele 
(PdxXBko), conditional null allele (floxE2), and conditional hypomorphic allele (flox123).  
Conditional alleles were recombined using the Ngn3Cre and RIPCre transgenic lines.  We 
assumed that phenotypes seen after recombination with Ngn3Cre but not after recombination 
with RIPCre would be indicative of specific functions of Pdx1 in endocrine progenitors.   
Deletion with either RIPCre or Ngn3Cre reduced the number of insulin-expressing 
cells per islet, and there was an increase in glucagon-, somatostatin- and PP-expressing cells 
per islet section.  To some extent, the observed increase in non-β endocrine cells probably 
resulted from concentration of cells that are normally on the periphery of the islet into the 
center of the islets.  The increased proliferation of glucagon cells observed previously in 
RIPCre;Pdx1floxE2/- mice (Gannon et al., in preparation) may also have contributed to the 
increased number of non-β islet cells.  Even taking these factors into account, the number of 
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PP cells appeared to be substantially increased in Ngn3Cre;Pdx1floxE2/- and 
Ngn3Cre;Pdx1flox123/- mice, but only slightly increased (if at all) in RIPCre;Pdx1flox123/- mice.  
Although more detailed analysis is required, our tentative conclusion is that impaired 
expression of Pdx1 in endocrine progenitors diverts a common β/PP progenitor to mostly 
make PP-expressing cells.  This hypothesis is consistent with lineage tracing results 
indicating that the PP promoter is active in progenitors of all PP and β cells of the adult 
pancreas, and probably also in precursors of the pancreatic somatostatin cells (Herrera, 
2002).   
There have been concerns about the specificity of the promoter in the PPCre 
transgene because it labels endocrine cells as early as E16.5 although PP protein is not 
typically detected until ~E18.5 (Myrsen-Axcrone et al., 1997).  The discrepancy between 
promoter activity and detection of PP protein may depend on the sensitivity of the method of 
protein detection and may also be influenced by post-transcriptional regulation of PP 
production.  The level of PP production is known to be regulated by parasympathetic 
signaling (Havel et al., 1993).  In Arx/Pax4 double null mutants, the islets of newborn mice 
are composed primarily of somatostatin-expressing cells, but after the pups eat their first 
meal many of the somatostatin-expressing cells begin to co-express PP (Collombat et al., 
2005).  It seems likely that these cells are related to the common PP/β/δ progenitor and retain 
the capacity to express PP, but do not express levels of PP that are detectable by IHC until 
stimulated by parasympathetic signaling in response to feeding.  Thus the early activity of 
PPCre is probably indicative of endogenous promoter activity in common precursor cells, 
which reflects competence to express PP even though PP protein does not accumulate to 
detectable levels until PP production is upregulated by later signals.   
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Role of Pdx1 in differentiation of endocrine progenitors 
 The increase in PP-expressing cells seen in Ngn3Cre;Pdx1flox/- but not in 
RIPCre;Pdx1flox123/- may occur because common PP/β progenitors lose the ability to activate 
β-specific genes and repress PP-specific genes when Pdx1 is deleted.  These findings suggest 
that there is a series of stage-specific requirements for Pdx1 in endocrine pancreas 
development.  Firstly, expression of Pdx1 during early pancreas development is required to 
produce endocrine progenitors.  Pdx1 is subsequently required in specified endocrine 
progenitors for selection of β- over PP-cell fate by common β/PP progenitors.  In 
differentiated endocrine cells, Pdx1 is required for maintenance and function of β cells.  The 
role of Pdx1 in the differentiation of β/PP progenitors may involve upregulation of Pdx1 
during β-cell differentiation.  Nishimura et al. (2006) showed that the timing of upregulation 
of Pdx1 correlated with a switch from MafB to MafA expression, suggesting that Pdx1 
upregulation may be a critical event in β-cell maturation.  We are planning to evaluate 
whether lack of the Area I-II-III enhancer inhibits this upregulation of Pdx1.   
 
Dominant phenotype of Pdx1ΔI-II-III probably results from role in endocrine progenitors 
 An interesting observation during characterization of the Pdx1ΔI-II-III allele was that 
Pdx1+/ΔI-II-III mice had more severely impaired glucose tolerance and more severely reduced 
Glut2 expression than Pdx1+/- mice (Fujitani et al., 2006).  This was surprising because the 
Pdx1ΔI-II-III allele appeared to be able to produce significantly more Pdx1 than the null allele 
(which does not make any), as evidenced by IHC for Pdx1 and the production of some 
relatively normal-looking pancreatic tissue in Pdx1ΔI-II-III/ΔI-II-III mice.   
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From our preliminary results, it appears that deletion of flox123 from differentiated β 
cells (mediated by RIPCre or RIPCreER) has a milder effect on glucose tolerance than 
deletion of floxE2, which yielded GTT results similar to Pdx1+/-.  These results are consistent 
with the Pdx1ΔI-II-III allele being hypomorphic in terms of level of Pdx1 production.  
However, the lack of (perhaps even one copy of) Area I-II-III may interfere with 
upregulation of Pdx1 in precursors that are making the transition from common progenitors 
to β cells, thereby interfering with β-cell maturation and possibly also generating more PP-
expressing cells.  This scenario could explain why deletion of Area I-II-III from endocrine 
progenitors has a stronger phenotype than Pdx1+/-, but a weaker effect when it is deleted in 
differentiated β cells.  In support of this putative role of Area I-II-III in endocrine 
progenitors, many islets in Pdx1+/ΔI-II-III mice were found to have unusually large numbers of 
PP cells (Fujitani et al., 2006).  
 
Pdx1 promotes expansion and maintenance of differentiated acinar tissue 
 Results from ElastaseCre-mediated deletion of the floxE2 allele indicate that there is a 
continuing requirement for Pdx1 in outgrowth of acinar tissue, in agreement with the 
previous analysis of Dox-repressible Pdx1 (Hale et al., 2005).  Furthermore, Pdx1 appears to 
be required in cells that express markers of differentiated acinar tissue (i.e., elastase), so it is 
not merely required for expansion of an undifferentiated progenitor population that 
subsequently undergoes acinar differentiation.   
Previous characterization of ElastaseCre;Pdx1floxE2/- mice in our lab indicated that 
exocrine mass was similar to wild type during embryogenesis but decreased progressively as 
the mice aged (Y. Kawaguchi and C.V.E. Wright, unpublished observations).  Together with 
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our current results, these findings suggest that acinar expansion is slowed when Pdx1 levels 
are very low (ElastaseCre;Pdx1flox123/-), and that acinar tissue actually regresses when Pdx1 is 
completely removed (ElastaseCre;Pdx1floxE2/-).  The reason that loss of acinar tissue was not 
seen after Dox-mediated repression of Pdx1 (Holland et al., 2002, Hale et al., 2005) may 
have been that the period of analysis was too short or there was still sufficient Pdx1 for 
acinar tissue maintenance even with repression by Dox.  We plan to use a tamoxifen-
inducible acinar-specific Cre driver to delete Pdx1 from mature acinar cells to determine 
whether Pdx1 continues to be required for maintenance and function of acinar tissue in the 
mature organ or if it is only required during the initial expansion of differentiating acinar 
tissue. 
 
Assessing efficiency of recombination of floxed alleles 
 It is difficult to reliably assess the efficiency of recombination of the floxed Pdx1 
alleles by the Cre driver lines used in this study.  We used the ROSA26R lacZ reporter to 
determine the typical pattern of lineage labeling by the Cre transgenes, but it was clear from 
co-staining Ngn3Cre;Pdx1floxE2/- tissues with XGal and Pdx1 IHC that Pdx1 was not absent 
from all of the cells with activated ROSA26R (Fig. 4.3).  However, judging by the small 
number of Pdx1+XGal+ cells, it appeared that Pdx1 was absent from most of the cells that 
had expressed Cre.  GTT analysis of RIPCre;Pdx1floxE2/+ mice revealed equivalent glucose 
intolerance to Pdx1+/- mice, providing additional evidence that floxE2 was efficiently 
recombined.   
Evaluating the efficiency of recombination of flox123 was more difficult because 
Pdx1 can be produced from the recombined allele and there was not a clear precedent for 
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predicting the severity of glucose intolerance after 100% recombination of flox123.  Reduced 
intensity of Pdx1 IHC in the islets of Ngn3Cre;Pdx1flox123/-, Ngn3CreBAC;Pdx1flox123/-, and 
RIPCre;Pdx1flox123/- mice (Fig. 4.4, 4.6, 4.7) indicated that flox123 was fairly efficiently 
recombined, although some cells with strong Pdx1 IHC were observed (e.g., Fig. 4.4F).   
Recombination efficiency varies significantly among floxed loci, making it difficult 
to use independent reporter alleles to trace the lineage of cells that have recombined a 
conditional allele.  For future experiments it may be beneficial to design conditional alleles 
that activate a reporter gene after deleting the intervening sequence.  For example, a 
conditional allele could be designed such that Cre-mediated deletion of an exon creates a null 
allele and simultaneously brings a reporter gene embedded in one intron under the regulation 
of a cryptic promoter inserted into another intron.  
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CHAPTER V 
 
DELAYED ACINAR DIFFERENTIATION AND ACCELERATED PRODUCTION OF 
ENDOCRINE CELLS IN EARLY PANCREATIC BUDS OF PTF1A+/- MICE 
 
Introduction 
Progenitor cells residing in the endodermal component of the early pancreatic buds 
give rise to the exocrine, endocrine and ductal tissues of the mature pancreas (Fontaine and 
LeDouarin, 1977; Gu et al., 2002), but the mechanism by which the proper number of 
progenitors is specified to each of the three main pancreatic lineages remains elusive.  
Experiments utilizing pancreatic bud explant cultures have shown that signals from 
mesenchyme promote outgrowth of exocrine tissue and inhibit differentiation of endocrine 
tissue (reviewed by Kim and Hebrok, 2001; Scharfmann, 2000).  Several molecules have 
been proposed to mediate these effects, including follistatin (Miralles et al., 1998), laminin 
(Li et al., 2004), and Notch signaling (Duvillie et al., 2006), perhaps through expression of 
Jagged ligands in the mesenchyme (Norgaard et al., 2003).  In addition, the TGFβ-related 
ligand Gdf11 is expressed in the epithelium of the developing pancreas and appears to inhibit 
proliferation of endocrine progenitors while promoting expansion of acinar tissue (Harmon et 
al., 2004).  In contrast, previous studies had implicated TGFβ and activin signaling in 
promoting endocrine differentiation (Sanvito et al., 1994; Yamaoka et al., 1998; Shiozaki et 
al., 1999; Kim et al., 2000; Ogihara et al., 2003) and inhibiting exocrine differentiation 
(Ritvos et al., 1995).  The intracellular factors that are responsible for the differential 
response of developing exocrine and endocrine pancreas to these signals have yet to be 
elucidated. 
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Two basic helix-loop-helix (bHLH) transcription factors, Pancreatic transcription 
factor 1a (Ptf1a) and Neurogenin 3 (Ngn3), are critical for generation of pancreatic exocrine 
and endocrine tissue, respectively (Krapp et al., 1998; Gradwohl et al., 2000).  Ptf1a is 
expressed in the pancreatic buds from as early as E9.0 (Krapp et al., 1998; Yoshitomi et al., 
2004) and lineage-labeling experiments showed that it is present in progenitors of the three 
main pancreatic lineages (Kawaguchi et al., 2002), although in adult pancreas its expression 
is restricted to acinar cells (Krapp et al., 1996).  Ngn3 is also present in the early pancreatic 
buds (Jensen et al., 2000a), but it is expressed exclusively in cells committed to endocrine 
cell fate (Gu et al., 2002).  Consistent with the restricted expression of Ngn3 in endocrine 
cells, Ngn3 null mice do not appear to have defects in development of exocrine pancreatic 
tissue (Gradwohl et al., 2000).  On the other hand, Ptf1a null mice suffer a complete failure 
of exocrine differentiation, but also produce many fewer pancreatic endocrine cells than 
wild-type mice.  The remaining endocrine cells fail to aggregate properly during 
development (Krapp et al., 1998; Kawaguchi et al., 2002).  It is not clear if the endocrine 
defects are secondary to defects in the exocrine pancreas, or if they reflect a role of Ptf1a in 
endocrine progenitors.  Common pancreatic progenitors are dominantly converted to 
endocrine cell fate by overexpression of Ngn3 (Apelqvist et al., 1999).  It is not yet known if 
overexpression of Ptf1a can alter the cell fate of early pancreatic progenitors. 
Notch signaling inhibits differentiation of pancreatic precursors resulting in greatly 
reduced expression of both Ngn3 and Ptf1a (Hald et al., 2003; Murtaugh et al., 2003).  These 
effects are mediated, at least in part, through induction of Hairy/Enhancer of Split 1 (Hes1), 
an inhibitory bHLH factor that is a direct repressor of Ngn3 (Lee et al., 2001) and probably 
also of Ptf1a (Fukuda et al., 2006a). Targeted inactivation of Hes1, or of genes encoding the 
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Notch ligand Delta-like 1 (Dll1) or the Notch cofactor Recombining Binding Protein 
Suppressor of Hairless J (RBPSUH-J), results in precocious activation of Ngn3 in the 
pancreatic buds, converting early pancreatic progenitors to glucagon-expressing cells (Jensen 
et al., 2000b; Apelqvist et al., 1999).  Hes1 null mice show ectopic activation of both Ptf1a 
and Ngn3 in the common bile duct, resulting in homeotic transformation of the bile duct into 
well-differentiated pancreatic tissue (Sumazaki et al., 2004; Fukuda et al., 2006a).  Although 
Hes1 appears to negatively regulate transcription of Ptf1a, there is some evidence that 
Notch1 and Ptf1a can cooperatively enhance transcription of target genes (Obata et al., 
2001).  Furthermore, RBPSUH-J can act as a coactivator for both Notch1 and Ptf1a (Beres et 
al., 2006).  Thus, it appears that Ptf1a activity is both positively and negatively regulated by 
components of the Notch signaling pathway. 
In addition to Ptf1a, a second bHLH factor, Mist1, is specifically expressed in the 
acinar cells of the adult pancreas (Pin et al., 2000, 2001).  Like Ptf1a, Mist1 is initially 
expressed in the pancreatic buds and its expression subsequently becomes restricted to 
developing and mature acinar cells, where it promotes transcription of factors involved in 
acinar cell function (Pin et al., 2001).  While Ptf1a regulates expression of digestive 
hormones (Cockell et al., 1989; Petrucco et al., 1990; Rose et al., 2001), Mist1 regulates 
expression of factors involved in vesicular transport and exocytosis (Rukstalis et al., 2003; 
Johnson et al., 2004; Luo et al., 2005).  In contrast to the severe disruption of pancreas 
development in Ptf1a-/- mutants, Mist1-/- mutants have no discernable defects in pancreas 
development (Pin et al., 2001), although they may be predisposed to ductal metaplasia (Zhu 
et al., 2004).   
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Because Ptf1a and Mist1 are bHLH family members that share very similar patterns 
of expression in developing and mature pancreas, we hypothesized that they might have 
redundant functions during development.  We generated Ptf1a-/-;Mist1-/- and Ptf1a+/-;Mist1-/- 
compound mutants to look for synthetic developmental phenotypes, but did not find any.  In 
the course of these experiments, however, we discovered that Ptf1a+/- mice exhibit a greatly 
decreased ratio of acinar/endocrine tissue production during early development.  Further 
examination revealed that this alteration resulted from simultaneous delay in acinar tissue 
differentiation and acceleration of endocrine tissue production. 
 
Results 
 
Lack of genetic interaction between Ptf1a and Mist1 
 XGal staining for a lacZ reporter knocked into the Mist1 locus was used to visualize 
pancreatic acinar tissue, revealing that heterozygosity or homozygosity for the Mist1lacZ null 
allele did not affect the extent of acinar tissue or the organization of pancreatic exocrine and 
endocrine structures that developed in newborn Ptf1a+/+ or Ptf1a+/- animals (Fig. 5.1).  In 
Ptf1a-/- animals, Mist1lacZ was not active in the pancreatic epithelial rudiment at E13.5 or P0 
suggesting that acinar cell differentiation is not initiated in the absence of Ptf1a (Fig. 5.2).  
Interestingly, the endocrine clusters that are found in the vicinity of the pancreatic rudiment 
in Ptf1a-/- mice (Krapp et al., 1998; Kawaguchi et al., 2002) were labeled by XGal in Ptf1a-/-
;Mist1+/- and Ptf1a-/-;Mist1-/- mice (Fig. 5.2).  One possibility is that these cells activated 
Mist1 transcription because they were originally specified as acinar cells and then converted 
to endocrine cell fate.  However, we also observed faint staining for Mist1lacZ in Ptf1a+/+ and 
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Fig. 5.1  Disruption of Mist1 does not impair pancreas morphogenesis in combination 
with Ptf1a+/-.  Offspring of Ptf1a+/-;Mist1+/- parents were dissected at P0 and posterior 
foregut tissues were stained with XGal to visualize nuclear lacZ reporter knocked into the 
Mist1 locus.  Whole-mount and histological analysis showed no difference in the extent and 
morphology of pancreatic exocrine and endocrine tissue in Mist1 homozygous or 
heterozygous null mutants in combination with Ptf1a+/-.  (A, B) Ptf1a+/-;Mist1+/-.  (C, D) 
Ptf1a+/-;Mist1-/-.  (E, F) Ptf1a+/+;Mist1-/-.  Blue/green nuclear stain in (B, D, F) is XGal 
staining of Mist1lacZ allele.  Brown stain in (B) is IHC for Pdx1.  Brown stain in (D, F) is IHC 
for glucagon.  Arrows indicate weakly XGal-stained nuclei in endocrine tissue. 
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Fig. 5.2  Mist1lacZ expressed in endocrine clusters but not epithelial rudiment of Ptf1a-/- 
mice.  (A, B) Ptf1a-/-;Mist1+/- P0.  (C, D) Ptf1a-/-;Mist1-/- P0.  (E, F) Ptf1a-/-;Mist1-/- E13.5.  
Mist1 nullizygosity did not appear to affect morphology of pancreatic rudiment or endocrine 
clusters in Ptf1a-/- mice.  (B, D, F) XGal (Mist1lacZ) and glucagon IHC staining of histological 
sections revealed that Mist1 was very rarely expressed in the duct-like rudiment (arrow in B), 
but was expressed in many of the endocrine clusters that bud off of the duct during 
embryogenesis.  (F) Glucagon-expressing cells bud from E13.5 ductal rudiment.  H&E 
counterstain.  Inset in (F), E13.5 endocrine cluster contains XGal-stained cells. 
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 Ptf1a+/- endocrine tissue (e.g. Fig. 5.1B,D,F, Fig. 5.3C), so it is possible that the XGal 
staining simply appears more intense in the Ptf1a-/- endocrine cells because of the lack of 
surrounding pancreatic tissue.  Overall, we did not see evidence for synthetic defects in 
pancreas development in compound mutants of Ptf1a and Mist1.  
 
Delayed acinar cell differentiation in Ptf1a+/- 
 Using Mist1lacZ as a reporter to assess acinar cell differentiation, we observed reduced 
XGal staining in Ptf1a+/- as compared to Ptf1a+/+ littermates at E13.5 (Fig. 5.3).  XGal 
staining on histological sections of E13.5 Ptf1a+/+;Mist1lacZ pancreas was localized to the tips 
of developing acini.  Similar acinar structures were identifiable in Ptf1a+/-;Mist1lacZ based on 
morphology, but the developing acini appeared to be smaller, fewer in number and lacked 
XGal staining.  Whole-mount IHC of E14.5 dorsal pancreatic buds revealed that Mist1 was 
detectable in both Ptf1a+/- and wild-type mice, but substantially more acinar tissue was 
present in wild type, particularly in regions proximal to the junction with the duodenum (Fig. 
5.4A,B).  Note that rotation of the tissue positioned the Ptf1a+/- pancreatic bud closer to the 
microscope objective, resulting in a relatively higher magnification than the wild-type bud in 
Fig. 5.4A.  Nonetheless, it is evident that the wild-type tissue contains more anti-Mist1-
stained acinar clusters.  Furthermore, because the size of individual acinar clusters does not 
differ between wild type and Ptf1a+/-, it can be inferred that the wild-type pancreatic bud in 
Fig. 5.4A is slightly larger at this stage, and is significantly thicker at the base of the bud.  In 
addition, the Ptf1a+/- bud appeared to contain more glucagon-expressing cells, which 
occupied a larger volume of the pancreatic bud than in wild type (as described in detail 
below).   
  119 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.3  E13.5 Ptf1a+/- embryos show retarded acinar development and accelerated 
endocrine development.  (A, C, E)  XGal staining for Mist1lacZ labeled tips of epithelial 
branches in dorsal (DP) and ventral (VP) pancreatic buds of Ptf1a+/+;Mist1-/- embryos.  (B, 
D, F) Ptf1a+/-;Mist1-/- embryos had less extensive epithelial branching with very little XGal 
staining of branch tips.  (C, D) Glucagon IHC showed substantially larger endocrine clusters 
in Ptf1a+/-.  (E, F) Insulin IHC indicated accelerated differentiation of insulin-producing cells 
in Ptf1a+/-.  Arrows in (C) and (F) indicate XGal-stained nuclei in endocrine clusters.  (C – F) 
Purple nuclei result from hematoxylin counterstain.  Turquoise nuclei result from XGal 
staining of Mist1lacZ.  
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Fig. 5.4  Delayed acinar cell differentiation in Ptf1a+/-  embryos at E14.5.  (A, B) Whole-
mount IHC for Mist1 (red) and glucagon (green) revealed decreased acinar/endocrine ratio in 
Ptf1a+/-.  (C, D) Fewer Mist1-positive (red) acinar cells were detectable per section in 
Ptf1a+/- and the intensity of staining appeared to be slightly weaker.  Nuclei are 
counterstained with TOTO-3 (blue).  (E, F) Less expression of amylase (red) in developing 
exocrine tissue of Ptf1a+/- embryos.  (C – F) The number of Ngn3-positive (green) cells was 
not appreciably different between wild type (C, E) and Ptf1a+/- (D, F).   
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IHC staining for Mist1 on histological sections of E14.5 pancreata indicated that 
fewer acinar cell nuclei expressed high levels of Mist1 in Ptf1a+/- embryos as compared to 
wild-type littermates (Fig. 5.4C,D).  The digestive enzyme amylase was abundantly 
expressed in wild-type pancreas at E14.5, but was more weakly expressed and present in 
substantially fewer cells in Ptf1a+/- littermates (Fig. 5.4E,F). 
 These results indicate that production of acinar tissue is delayed in Ptf1a+/- mice at 
mid-embryogenesis, and the decreased mass of acinar tissue at these stages is accompanied 
by a delay in the initiation of expression of early (Mist1) and late (amylase) markers of acinar 
cell differentiation.  Decreased acinar tissue volume was not observed in Ptf1a+/- newborns 
(e.g. Fig. 5.1), suggesting that acinar tissue production “catches up” later during 
embryogenesis.  We still need to examine later embryonic stages to evaluate this hypothetical 
“catch-up” process. 
 
Accelerated endocrine cell differentiation in Ptf1a+/- 
 At the same stages when production of acinar tissue lagged in Ptf1a+/- embryos, there 
appeared to be an increased amount of tissue expressing the endocrine hormones glucagon 
and insulin.  As a result of the delayed production of acinar tissue, it is possible that 
endocrine tissue appeared to be increased simply due to the same amount of endocrine tissue 
being concentrated into a smaller pancreatic organ.  If this were the case, we might expect to 
see more endocrine clusters per section but not necessarily larger individual clusters.  On the 
contrary, anti-glucagon IHC indicated that the endocrine clusters in Ptf1a+/- contained more 
cells, suggesting that there was increased proliferation of endocrine cells in Ptf1a+/- embryos 
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rather than crowding of the wild-type number of clusters (Fig. 5.3C,D).  Whole-mount IHC 
analysis also indicated that the overall volume of glucagon clusters was increased in Ptf1a+/- 
embryos (Fig. 5.4A,B).  In wild-type embryos at E13.5, insulin-positive cells were rare and 
scattered, whereas they appeared to be more abundant and clustered in Ptf1a+/- embryos (Fig. 
5.3E,F).  These results suggest that endocrine cell proliferation and differentiation may be 
accelerated in Ptf1a+/- embryos. 
 Increased production of endocrine cells was also apparent at earlier stages of 
development.  The size of glucagon-positive endocrine cords appeared to be increased at 
E12.5 in Ptf1a+/-, and the number of Ngn3-expressing cells also appeared to be increased at 
this stage (Fig. 5.5C,D).  At E10.5 the proportion of pancreatic bud cells that expressed 
glucagon was greater in Ptf1a+/- embryos.  The number of Ngn3-expressing cells appeared to 
be slightly increased in Ptf1a+/-, but we are not yet certain if this is a consistent trend (Fig. 
5.5A,B, Fig. 5.6).  Overall, the increase in hormone-expressing cells appeared to be greater 
than the increase (if any) in Ngn3-expressing cells, suggesting that increased endocrine mass 
is primarily attributable to increased proliferation of endocrine cells rather than increased 
specification of common pancreatic progenitors to endocrine cell fate.  Quantitative analysis 
of a larger number of embryos will be required to determine if the number of Ngn3-positive 
cells is increased.  We also plan to examine markers of proliferation in hormone-positive and 
Pax6-positive endocrine tissue at these stages.   
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Clusters of Xgal-stained cells in rostral duodenal epithelium of Pdx1-/-;Mist1+/lacZ 
 One interpretation of the finding that endocrine clusters in Ptf1a-/-;Mist1lacZ mice were 
labeled by XGal is that progenitors that were originally specified as acinar cells were 
reassigned to endocrine fate in the absence of Ptf1a.  If this hypothesis is true, then the 
transdifferentiated cells were able to retain the nuclear-localized β-galactosidase protein that 
was generated when they initially activated Mist1 transcription.  In light of the possibility 
that Mist1lacZ might serve as a lineage label for acinar progenitors, we examined newborn 
Pdx1-/-;Mist1+/lacZ mice by whole-mount XGal staining to determine if any of the rudimentary 
pancreatic tissue remaining in Pdx1-/- mutants may have undergone early steps of acinar 
differentiation.   
XGal labeling was not detected in the dorsal pancreatic rudiment, but patches of 
XGal-stained cells were found in the epithelium of the rostral duodenum (Fig. 5.7).  
Scattered individual Mist1-positive cells were present in wild-type duodenum (Fig. 5.7E), but 
clusters of strongly stained cells were only seen in Pdx1-/- duodena.  The pattern of duodenal 
Xgal labeling was reminiscent of the location of lineage-labeled cells that take residence in 
the duodenum of Ptf1acre/cre;ROSA26R mice (Kawaguchi et al., 2002).  This finding raises the 
possibility that early acinar specification occurs in the ventral bud of Pdx1-/- embryos and the 
cells that produced β-galactosidase subsequently come to reside in the duodenal epithelium 
after the ventral bud is reincorporated into the duodenum.  This possibility could be tested 
more rigorously using a mouse expressing Cre under the control of Mist1 regulatory 
elements.   
An alternative explanation is that improper patterning of the gastroduodenal junction 
in Pdx1-/- mutants results in ectopic expression of Mist1 in the rostral duodeum in a pattern  
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Fig. 5.7  Poorly differentiated duodenal epithelium of Pdx1-/- mice ectopically expresses 
Mist1lacZ.  Many patches of Mist1lacZ-expressing cells (blue) were found on the 
dorsoposterior aspect of the rostral duodenum (B), and a few on the ventroanterior aspect 
(A), in newborn Pdx1-/-;Mist1+/- mice.  Arrow in (B) indicates pancreatic rudiment.   
(C, D) Histological anaylsis indicated that the XGal-stained cells (blue) were localized to 
clusters of epithelial cells in dysmorphic regions of the rostral duodenum.  (E) In Pdx1+/+ 
duodenum, Mist1lacZ expression (blue) was found in scattered epithelial cells.  (F) Mist1lacZ 
was expressed in secretory glands of the stomach in Pdx1+/+;Mist1-/- mice.  Sections in (C, 
D) are counterstained with eosin.  Pdx1 IHC (brown) is shown in (E).   
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similar to that normally seen in the glandular tissues of the stomach (e.g., Fig. 7F).  Further 
evidence for the latter hypothesis could be obtained by examining embryonic stages to 
determine if the onset of Mist1 expression in the rostral duodenum of Pdx1-/- embryos 
matches the timing of Mist1 induction in stomach glands.  We also plan to use IHC analysis 
to determine if Mist1-postive patches of Pdx1-/- duodenum ectopically express stomach 
markers or downregulate duodenal markers. 
 
Discussion 
 Due to their similar developmental expression patterns and roles in promoting acinar-
cell-specific gene expression, we predicted that Mist1 and Ptf1a might act in the same 
pathways during acinar cell development, or perhaps even in early pancreatic bud 
development, and that a synthetic defect might be seen in Ptf1a+/-;Mist1-/- embryos.  We did 
not, however, detect any synthetic developmental defects in mice with various combinations 
of Ptf1a and Mist1 null alleles.  We conclude that although Mist1 and Ptf1a are involved in 
the related but distinct processes of enzyme production and transport in mature acinar cells, 
they do not appear to contribute to the same pathways in acinar cell development. 
 Mist1lacZ proved to be a useful marker for the early stages of acinar cell development, 
and during our analysis of Ptf1acre;Mist1lacZ compound mutants we noticed that acinar cell 
development is delayed in Ptf1a+/- embryos.  Further characterization of differential marker 
expression between Ptf1a+/- and wild-type embryos revealed that along with a delay in the 
activation of acinar cell markers and outgrowth of acinar tissue, there appears to be increased 
production of pancreatic endocrine cells in mid-gestation Ptf1a+/- embryos.  Much work 
remains to be done in analyzing the nature of the increase in endocrine tissue, such as 
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examining whether the increase results primarily from enhanced proliferation of specified 
endocrine cells or from increased specification of common progenitors to endocrine cell fate.   
Because the relative endocrine and exocrine mass does not appear to be abnormal in 
newborn Ptf1a+/- mice, we hypothesize that there is a catch-up process during late gestation.  
We plan to characterize this catch-up process in terms of whether we can observe increased 
proliferation of acinar tissue and decreased proliferation of endocrine tissue during late 
embryogenesis to compensate for the delayed acinar differentiation and increased generation 
of endocrine tissue during early pancreatic development.  Characterization of the catch-up 
process will hopefully provide insight into the mechanism regulating final organ size during 
normal pancreatic organogenesis. 
 Based on the absolute requirement for Ptf1a in the development of the pancreatic 
exocrine lineages (Krapp et al., 1998), a likely reason for delayed acinar development in 
Ptf1a+/- embryos is that retarded accumulation of Ptf1a protein results in slower triggering of 
acinar cell specification.  Because Ptf1a has been shown to be expressed in progenitors of 
most pancreatic endocrine cells (Kawaguchi et al., 2002), the expansion of early pancreatic 
endocrine development may be a direct effect of a decreased level of Ptf1a in endocrine 
progenitors.  Another possibility is that accelerated endocrine development is secondary to 
the delayed differentiation of acinar tissue.   
A candidate mechanism for indirectly linking the rates of acinar and endocrine cell 
differentiation is secretion of the TGFβ-family molecule Gdf11 by developing acinar tissue.  
Gdf11 is expressed in the early pancreatic bud epithelium and becomes restricted to acinar 
cells during development (Harmon et al., 2004).  Gdf11-/- mutants have increased 
proliferation of endocrine progenitors and decreased production of acinar tissue, making it a 
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good candidate for a putative signal from developing acinar cells to limit expansion of the 
endocrine compartment.  We plan to test if Gdf11 localizes to specified acinar progenitors 
during early pancreatic development based on co-localization of Gdf11 and Mist1 
expression, and whether pancreatic Gdf11 expression is delayed in Ptf1a+/- embryos.   
Another potential mechanism for accelerated endocrine development in Ptf1a+/- 
mutants is cooperation between Ptf1a and the Notch signaling pathway to repress Ngn3 
expression.  To test if accelerated endocrine development in Ptf1a+/- embryos results from 
enhanced Ngn3 expression, we plan to generate Ptf1a+/-;Ngn3+/- double heterozygous mice to 
see if equizygosity of the two genes restores balance to the relative amount of acinar and 
endocrine cells in early embryos.   
A third mechanism to be evaluated is perturbed communication between pancreatic 
epithelium and mesenchyme in Ptf1a heterozygotes.  For instance, if Ptf1a promotes the 
secretion of a signal from the epithelium that enhances the release of follistatin from the 
mesenchyme, then a decreased level of Ptf1a could indirectly increase TGFβ/Activin 
signaling, which would in turn stimulate endocrine differentiation.  Another possibility is that 
higher doses of proliferative signals from the mesenchyme, such as FGFs, reach the 
endocrine progenitors when the mass of surrounding acinar tissue is decreased due to 
insufficient levels of Ptf1a.  In summary, we have uncovered a novel, dosage-dependent role 
of Ptf1a in regulating the relative rates of endocrine and acinar tissue production from 
pancreatic progenitors, but much work remains to be done to characterize the mechanism 
underlying this phenotype. 
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CHAPTER VI 
 
CONCLUSIONS AND FUTURE AIMS 
 
Conclusions 
 
Roles of distal and proximal cis-regulatory regions of Pdx1 
 In the Pdx1 locus, almost all of the non-coding sequences that show significant 
conservation between mice and humans reside within 10 kb 5’ of the transcription start site.  
The proximal 4.6 kb of this region was shown to be sufficient to recapitulate the expression 
pattern of Pdx1 in developing and mature mice (Stoffers et al., 1999) despite the fact that 
Area IV, the largest conserved region (Fig. 1.6) and first shown to mediate β-cell-specific 
activity (Sharma et al., 1996), is not included in the 4.6 kb region.  Our transgene 
complementation experiment (Chapter 3) revealed that cis-elements outside of the proximal 
4.6 kb region are required for normal levels of Pdx1 expression in mature duodenal and 
stomach epithelia.  In addition, mice carrying the transgene produced more Pdx1 in mature 
pancreatic acinar, α, and PP cells than did wild-type controls, indicating that distal cis-
elements may have a repressive influence on Pdx1 transcription in these tissues. 
Interestingly, the embryonic expression domain of Pdx1 was not affected by the lack 
of distal regulatory elements (Chapter 3) nor was it substantially altered by absence of the 
proximal enhancer region Area I-II-III (Fujitani et al., 2006).  These results suggest 
functional redundancy between proximal and distal cis-regulatory elements for mediating 
transcriptional activation of Pdx1 in response to the development cues that dictate the early 
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expression pattern of Pdx1.  Redundancy between the proximal and distal regions during 
embryogenesis is consistent with the presence of binding sites for FoxA and Hnf factors in 
both regions (Sharma et al., 1996; Wu et al., 1997; Gerrish et al., 2000; Marshak et al., 2000; 
Gerrish et al., 2001; Jacquemin et al., 2003).  Expression of the three FoxA factors (Ang et 
al., 1993; Monaghan et al., 1993; Sasaki and Hogan, 1993), Hnf1β (Barbacci et al., 1999), 
Hnf4 (Duncan et al., 1994) and Hnf6 (Jacquemin et al., 2003) precedes expression of Pdx1 in 
posterior foregut endoderm, and it has been proposed that they act as a core endodermal 
genetic network by reinforcing and stabilizing their own expression and promoting the 
expression of other endoderm-specific genes (Shih and Stoffel, 2001; Jensen, 2004; Odom et 
al., 2004).  It appears that this core endodermal network can interact with multiple regions of 
the Pdx1 promoter and as long as some of those regions are intact, then there is sufficient 
recruitment of the core endodermal factors to activate Pdx1 in its normal expression domain.  
Because the embryonic domain of Pdx1 expression was not expanded in either the transgene-
rescue or Pdx1ΔI-II-III mutants, it can be inferred that the binding of repressors to proximal or 
distal 5’ regions is not critical for restricting the early Pdx1 expression domain.  These 
findings suggest that the early Pdx1 expression domain is dictated primarily by the 
distribution and level of activity of the transactivators of Pdx1. 
 Redundant roles for Area IV and Area II may also contribute to functional 
redundancy between proximal and distal promoter regions.  Areas I, II and IV have β-cell-
specific transcriptional activity in isolation, and the level of activity increases synergistically 
when these areas are combined (Gerrish et al., 2004; Van Velkinburgh et al., 2005).  
Although Area II appears to be the most important for expression in murine β cells (Samaras 
et al., 2002), only Areas I, III and IV are present in chickens (Gerrish et al., 2004).  When 
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considered together with our findings that proximal (including Areas I, II, and III) and distal 
(including Area IV) regions of the Pdx1 promoter have redundant functions in promoting 
embryonic expression of Pdx1, the phylogenetic analysis suggests that perhaps ancient 
functions of Area IV have been subsumed by Area II in mammals, but mammalian Area IV 
retains the capacity to partially compensate for deletion of Area II. 
 In situ hybridization for Pdx1 message in the duodenum indicated that it is 
transcribed mainly in the crypts (Stoffers et al., 1999), where the adult intestinal stem cells 
are located.  Our analysis of the consequences of reduced duodenal Pdx1 expression in the 
transgene-rescue mice revealed a dose-dependent influence of Pdx1 on the postnatal 
production of GIP enteroendocrine cells.  While Pdx1 had previously been shown to activate 
transcription of GIP (Jepeal et al., 2005), our results demonstrated that Pdx1 also determines 
the rate of production of GIP cells from crypt progenitors.  Lineage analysis of intestinal 
epithelial cells (reviewed by Schonhoff et al., 2004a) has shown that Notch signaling inhibits 
expression of Math1, which promotes differentiation of common progenitors to secretory 
rather than absorptive cell lineages.  A subset of the Math1-expressing cells activate 
expression of Ngn3 and subsequently differentiate to produce enteroendocrine cells.  Very 
little is known about the mechanisms that allocate Ngn3-expressing progenitors to the 
various enteroendocrine lineages, but our results indicate that Pdx1 plays a role in this 
process by promoting GIP cell fate. 
 
Pdx1 regulates ratio of β /PP cells 
In addition to demonstrating a role of Pdx1 in regulating the cell fate of 
enteroendocrine precursors, we have uncovered a similar role of Pdx1 in the lineage 
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allocation of pancreatic endocrine progenitors.  It had been difficult to assess the role of Pdx1 
in endocrine progenitors because germline inactivation of Pdx1 disrupts development of the 
pancreatic buds and global repression of Pdx1 during mid-embryogenesis arrests all aspects 
of pancreas development (Jonsson et al., 1994; Hale et al., 2005).  By using Ngn3Cre 
transgenes to recombine floxed alleles of Pdx1, we have demonstrated that the level of Pdx1 
expression in endocrine progenitors regulates the relative number of β and PP cells that are 
produced (Chapter 4).  This result is consistent with previous studies indicating that β and PP 
cells derive from a common progenitor cell that is distinct from the α cell lineage (Herrera, 
1994; Herrera, 2000).   
The mechanism by which PP expression is increased in Ngn3Cre;Pdx1flox/- mice 
remains to be elucidated.  Our immunohistochemical (IHC) analysis of PP expression 
indicates that low levels of PP expression are detectable in many β cells of neonatal wild-
type mice.  More thorough analysis is required, but it appears that the low-level co-
expression of PP diminishes as the mice get older, suggesting that PP expression is a remnant 
of the bipotential state of β/PP precursors that is progressively lost as the β cells mature.  
Thus, one explanation for the simultaneous decrease in insulin-expression and increase in 
PP-expression in Ngn3Cre;Pdx1flox/- mice could be that Pdx1 directly represses PP expression 
in specified β-cell precursors.  In this case, common β/PP progenitors might be correctly 
specified to β-cell fate after conditional deletion of Pdx1, but the lack of Pdx1 results in 
decreased transcription of Insulin and failure to repress expression of PP.  This hypothesis 
could be tested by evaluating if the supernumerary PP-expressing cells in Ngn3Cre;Pdx1flox/- 
animals have the characteristic catecholamine responsiveness (Havel et al., 1993) and 
electron micrographic characteristics (Larsson et al., 1976) of proper PP cells, or if they 
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inappropriately express factors typically found in β cells but not in PP cells, such as MafA, 
Nkx6.1, and Nkx2.2.   
If the extra PP-expressing cells are found to be properly differentiated PP cells, it 
would support the alternative hypothesis that conditional deletion of Pdx1 tips the balance of 
common β/PP progenitors toward production of PP cells.  A caveat to our observation of 
decreasing levels of PP in young, wild-type β cells is that the closely related peptide NPY is 
known to be expressed in immature β cells (Myrsen-Axcrona et al., 1997).  It will be 
important to confirm the specificity of detection of PP versus NPY. 
 
Pdx1 influences cell fate decisions downstream of Ngn3 
Our experiments fill a gap in the previous understanding of the role of Pdx1 in 
endocrine cell development in the posterior foregut.  Previous analysis of Pdx1-/- mutant mice 
had revealed gross morphological defects of the pancreas, rostral duodenum, pylorus and 
common bile duct (Jonsson et al., 1994; Offield et al., 1996; Fukuda et al., 2006b), and 
several in vitro and in vivo studies demonstrated that Pdx1 is a positive transcriptional 
regulator of genes encoding the hormones insulin, somatostatin and GIP, as well as factors 
involved in β-cell function (Ohlsson et al., 1993; Peers et al., 1994; Peshavaria et al., 1994; 
Leonard et al., 1993; Miller et al., 1994; Waeber et al., 1996; Watada et al., 1996; Jepeal et 
al., 2005).  We have now shown that, in addition to regulating the function of foregut 
endocrine cells and patterning the organs in which they reside, Pdx1 acts downstream of 
Ngn3 in both the pancreas and duodenum to influence the lineage choice of common 
endocrine progenitors. 
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 Our hypothesis that the level of expression of Pdx1 in progenitors influences cell fate 
choice has important ramifications for efforts to produce well-differentiated tissues from 
stem cells in vitro.  Current protocols for guiding the differentiation of stem cells typically 
use RT-PCR to check for the presence of transcripts that are thought to be important markers 
for intermediate stages of differentiation.  Our findings indicate that the efficient production 
of β cells requires a higher level of Pdx1 than is needed for the production of endocrine 
precursors.  This suggests that simply assessing the presence of established markers for 
progenitor cells may not be adequate to insure that stem cells are following the desired 
pathway of differentiation.  In order to refine multi-step protocols for differentiation of stem 
cells into β cells or other mature cell types, it may be important to monitor the level of 
expression of key transcriptional regulators at intermediate steps, e.g. using real-time PCR, to 
make sure that they are sufficient to support differentiation to the desired mature cell fate. 
 
Future directions 
 
Ptf1a haploinsufficiency phenotype 
 Many studies have shown that intercellular signaling influences the balance between 
exocrine and endocrine differentiation of the pancreatic buds (reviewed by Scharfmann, 
2000), but our characterization of Ptf1a+/- embryos may be the first example of a 
transcription factor having opposite effects on the rates of exocrine and endocrine 
differentiation without arresting either process.  Because Ptf1a is transcribed in common 
progenitors of endocrine and exocrine pancreatic tissue, one hypothesis is that the level of 
Ptf1a protein influences the response of common progenitors to extracellular cues that favor 
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exocrine over endocrine differentiation.  An alternative hypothesis, considering that Ptf1a is 
required for acinar cell differentiation, is that reduced expression of Ptf1a in Ptf1a+/- embryos 
results in a cell-autonomous retardation of acinar differentiation, which leads to an indirect 
stimulation of endocrine cell proliferation.   
In either case, further analysis of the Ptf1a haploinsufficiency phenotype should help 
to elucidate the mechanisms that regulate production of the correct proportion of endocrine 
and exocrine pancreatic tissue.  The first step will be to determine the mechanism of 
expansion of endocrine tissue in early Ptf1a+/- pancreatic buds.  For instance, are more of the 
early bud cells being specified to endocrine fate by ectopic activation of Ngn3, or are cells 
that have already been specified to endocrine fate undergoing extra cycles of proliferation?  
The next question to be addressed is whether the Ptf1a+/- pancreatic buds have an altered 
response to soluble factors that have been previously shown to influence exocrine and 
endocrine differentiation of cultured pancreatic buds. 
 
Conditional deletion of floxed Pdx1 alleles 
 We have shown that recombination of conditional null and hypomorphic alleles of 
Pdx1 in endocrine progenitors (via Ngn3Cre transgenes) results in increased PP expression in 
the islets of young mice.  An important next step will be to examine the embryonic endocrine 
progenitors in the conditional mutants to determine if Pdx1 expression decreases rapidly after 
expression of Ngn3, and if alteration in expression of insulin and PP is apparent during early 
stages of endocrine development.  As discussed above, the phenotype of the supernumerary 
PP-expressing cells needs to be characterized to determine if they are properly differentiated 
PP cells or poorly differentiated β cells.  It would also be interesting to test whether Pdx1 can 
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directly repress the PP promoter in cultured cells, and conversely whether knockdown of 
Pdx1 expression in cultured β cells results in upregulation of endogenous PP expression.  To 
test the limits of the hypothesis that the level of Pdx1 in endocrine progenitors determines the 
relative proportion of β and PP cells, the recently described Cre-activatable Pdx1 transgene 
(Miyatsuka et al., 2003) could be used to overexpress Pdx1 in endocrine progenitors and 
potentially drive more progenitors to β cell fate.   
 
Regulation of Pdx1 promoter activity 
 Now that we have discovered that regulatory regions outside of the proximal 4.6 kb 
promoter sequence of Pdx1 play a critical role in promoting expression in adult duodenum 
and stomach, the first outstanding task is to map the distal enhancer elements that promote 
expression in mature gut mucosa.  Based on the hypothesis that phylogenetically conserved 
sequences regulate conserved expression patterns, the top candidates to examine are Area IV 
and the two uncharacterized conserved regions that lie between -7 and -10 kb (Fig. 1.6).  If a 
Pdx1-expressing duodenal epithelial cell line can be obtained, it should be a valuable tool for 
mapping duodenal enhancers in the Pdx1 promoter.  In addition, we are developing a 
cassette-acceptor locus for the 5’ region of Pdx1 to facilitate rapid, iterative mutagenesis of 
Pdx1 promoter sequences.  This tool will be used to delete Area IV from the endogenous 
Pdx1 locus, and to make compound mutations in proximal and distal elements to further 
characterize the redundant developmental roles described above.   
An important future direction in characterizing the developmental regulation of Pdx1 
expression will be to determine how intercellular signaling influences transcription of Pdx1.  
Because the overall extent of the embryonic Pdx1 expression domain did not appear to be 
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altered by loss of either distal or proximal regulatory elements, it seems likely that the initial 
Pdx1 expression domain is determined primarily by regulation of Pdx1 transactivators via 
extracellular cues.  Studies of Pdx1 promoter occupancy and chromatin structure in response 
to soluble factors or ectopic activation of signaling pathways might provide insight into these 
developmental gene regulatory mechanisms. 
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